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GENETICALLY MODIFIED PLANTS: 
A NEED FOR INTERNATIONAL 
REGULATION 
HENRIQUE FREIRE DE OLIVEIRA SOUZA· 
I. INTRODUCTION 
One of the most sensitive aspects of the technological evolution is linked 
with biotechnology. In this field human beings modify and create new 
forms of life and food. Th~ field raises questions of ethics, questions of 
how to protect this "new" creation or version, questions of how 
commercially to explore this "new" creation or version, questions of how 
to protect consumers from potential or possible negative side effects of 
this "new" creation or version, and questions of how this "new" creation 
or version will affect the environment. Thus, biotechnology evokes both 
hope and fear. 
Amongst all the possible issues related to biotechnology, the issue 
concerning genetically modified food (GMF) has special importance: 
while the "creators" of this kind of food are starting to exploit it 
commercially, resistance to genetically modified food has risen under the 
leadership of the European countries. This paper will be confined only to 
genetically modified plants (GMP) , and their impacts on both the 
environment and the economy. 
* Brazilian lawyer. Degree in Law, Specialization in Economic Law, Rio de Janeiro State 
University School of Law; Specialization in Private Law, Fluminense Federal University School of 
Law. LL.M. International Legal Studies, Golden Gate University School of Law; M.A. candidate 
International Commercial Law, University of California at Davis School of Law. Member of the 
Federaci6n Interamericana de Abogados. The author would like to thank Professor Sompong 
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In this paper, an overview will be provided of the issues involved in the 
context of GMP, including aspects of consumer and environmental 
protection, international trade, and intellectual property. Then, and using 
as a reference the ongoing discussion in Brazil concerning genetically 
modified soy, an analysis will be made of the questions relating to 
Hlbeling and moratorium in the exploitation of these products. Finally, 
and after analyzing the situation mentioned above, and considering some 
of the general principles and concepts in international environmental law 
(specifically: state responsibility, the duty to assess environmental 
impacts, the obligation not to cause environmental hann, and the 
precautionary principle) a conclusion may be warranted. This conclusion 
is that an international regulation establishing not only a moratorium in 
the exploitation of GMP but also some minimum standards and an 
international label requirement should be introduced to counterbalance 
the economic power of the multinational companies acting in this field 
over develpping or the less developed countries; second, more time 
should be provided for detailed studies on the environmental and health 
impacts of this kind of harvest; third, it will be necessary to protect the 
consumers; and finally, it must be in accord with general concepts and 
principles of international environmental law. 
ll. DEVELOPMENT 
A. BIOTECHNOLOGY AND PLANTS 
Four questions will be answered here: (a) why has this subject attracted 
so much attention? (b) What is the relationship between biotechnology 
and intellectual property rights? (c) What are the risks and benefits 
associated with this subject? (d) Balancing the benefits and risks, is GMP 
safe food? 
1. Historical Evolution (Including the Role of Intellectual Property) 
Instead of preparing a detailed and chronological graphic of the evolution 
of biotechnology, it will be simpler to emphasize, as Sara Dunn explains, 
that "genetic manipulation to enhance favorable characteristics of 
agricultural product is not a new phenomenon. Pests and drought have 
always influenced genetic composition through the process of natural 
selection. Historically, producers have also influenced natural selection 
favoring crops that were bred to enhance desirable traits such as higher 
2
Annual Survey of International & Comparative Law, Vol. 6 [2000], Iss. 1, Art. 8
http://digitalcommons.law.ggu.edu/annlsurvey/vol6/iss1/8
2000] GENETIC ALL Y MODIFIED PLANTS 131 
yields or drought resistance.,,1 So, the question now is: why is this 
subject, this "old issue," this "old practice" attracting so much attention 
nowadays? And the answer is that: times have changed, the technology 
now is unique and widespread, and man now is starting to understand 
and fear the basic rule of evolution: adapt or die. 
As Ms. Dunn observes, biotechnology is currently "among the faster 
growing industries in the world, with no end to growth in sight.,,2 This 
means that the time for a new product to be released in the market today 
is shorter than before, and likewise that the time for consumers (farmers 
or the general population) to assess the product and its potential or real 
side effects is also short. Consequently, consumers are using and 
consuming the product without, most of the time, being properly 
informed or without having enough time to evaluate information 
concerning the health or environmental side effects of the product. The 
irony is that even though man is able to create "new lives," he is not able, 
at this time, to explain the effective consequences of the interaction of 
this "new life" with another specific form of life in a specific case, or 
with the environment in general. 
Not only is time short, and the number of new biotech products being 
released high, but technology nowadays is unique, and sometimes unreal 
and inexplicable to the majority of people. One could say that all 
technological process will always seem unique, unreal and inexplicable 
for the majority of people, and this is true. The problem here is that the 
technology in this field is becoming widespread, at least in terms of final 
products, and a good example is the fact that 60% to 70% of foods sold 
in the U.S.A contain substances developed through genetic engineering? 
This happens in order to provide protection against insect disease, or 
develop resistance to some chemicals, or improve its intrinsic quality.4 It 
means that two basic rights of consumers have been violated: the right to 
be informed, and the right to make choices. 
The combination of "time and technology" would not be enough to 
attract all this attention without the existence of a growing trend of 
1. Sara M. Dunn, From Flav'r Sav'r to Environmental Saver? Biotechnology and the Future 
of Agriculture, International Trade, and the Environment, 9 COLO. J. INT'L ENVTL. L. & POL'y 145, 
148-149 (1998). 
2. ld., at 150. Moreover, "between 1985 and 1990, biotechnology patent applications 
increased by fifteen percent annually in the United States and total products sales are expected to 
exceed $50 billion by the year 2000." 
3. CNN.com, U.S., Europe React Differently over Modified Foods (last visited Sept. 2, 1999) 
<cnn.ComINA TUREl9907/08/genetics.enn/>. 
4. Dunn, supra note 1 , at 149. 
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respect for the environment. This is a consequence of a great change -
provoked by fear or education - in the way in which man sees his own 
relationship with the environment. If in the past this was a win-lose 
relationship, nowadays it is becoming a win-win relationship, and man 
today, unlIke in the past, not only pays more attention to the 
environmental consequences of his acts, but· also understands that the 
only way to survive is by keeping the environment good enough to 
support life. In this new kind of relationship agriculture has a special 
role, because, as John Barton says, agriculture "directly uses over a third 
of the earth's land areas.,,5 
Another important point to be emphasized concerns how biotechnology 
and plants are related to intellectual property rights (IPR) , 6 and the main 
issue here is: should a new form of life be protected by IPR? The fact is 
that using biotechnology, man has been re-creating nature through the 
creation of new forms of life (plants and animals), which has provoked a 
re-thinking of moral, ethical and legal values. In order to understand the 
actual situation, the following general comments are essential: 
Although it is clear that the main purpose of IPR is, according to 
Margereth Barret "to ensure a rich, diverse and competitive 
marketplace,,,7 the definition, the scope,8 the kind of protection9 and the 
remedies associated with IPR vary enormously around the world. The 
problem is even worse when considering that protection, if granted, will 
have effect only in the territory of the state where protection is granted, 
independently of the fact that nowadays "thoughts" [and sometimes also 
goods] are not restricted by any geographical barrier: they can go 
5. John H. Barton, Biotechnology, the Environment, and Intellectual Agricultural Trade, 9 
GEO. !NT'!.. ENVTL. L. REv. 95, n.1 (1996). 
6. There are three basic ways of protecting intellectual property rights: trademark, copyright 
and patent. A new way would be related with breeder's rights. 
7. MARGRETH BARRET, INTELLECTUAL PROPERTY - CASES AND MATERIALS, St. Paul, MN: 
West Publishing Co, at 2 (1995). 
8. GEORGE A. BERMAN ET AL., CASES AND MATERIALS ON EUROPEAN COMMUNITY LAW, St. 
Paul, MN: West Publishing, at 396 (1993). "The three traditional categories of such rights, 
recognized by almost all modem free-enterprise legal systems (but rejected, until recently, by 
Marxist and many mixed-economy legal systems) are patents, trademarks and copyrights." 
9. Hugh Cameron, International Collaborative R&D Intellectual Property Rights in 
Facilitating International Technology Co-Operation Proceedings of the Seoul Conference, 
DSTIISTPfflP (97) 141FINAL, Mar. 28, 1999, at 89 <http://www.oecd.orgldstilstils_tJinteJ 
prod/seoul.htm>. One example here is provided when comparing patenting systems; so, for example 
and among other dissimilarities: (1) the patent will be granted in the European Patent Office and 
Japan for the first to file, in the U.S. Patent Office for the first to invent; (2) there is no patent for 
discovery in the European Patent Office and Japan, but this kind of patent exists in the U.S. Patent 
Office; and, (3) there is no grace period in the European Patent Office; in Japan this period is six 
months and in the US it is twelve months. 
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everywhere (it is the phenomenon of globalization). In order to try to 
achieve a more effective standard of protection as well as extraterritorial 
protection, a number of international multilateral and bilateral 
agreements have been signed, including: (a) the Berne Convention for 
the Protection of Literary and Artistic Works (Paris Act, July 24, 1971);10 
(b) the Paris Convention for the Protection of Industrial Property signed 
on March 20, 1883, as revised and amended;ll and (c) the Agreement on 
Trade-Related Aspects of Intellectual Property Rights, Including Trade 
and Counterfeited Goods (TRIPs).12 Moreover there is a tendency not 
only to harmonize the rules, but also to grant extraterritorial protection in 
terms of IPR; two examples are worth mentioning: one is the fact that the 
Members of NAFf A (North American Free Trade Agreement) are trying 
to unify or harmonize the protection of intellectual property among their 
Member States,13 and another example is that the European Community 
is also trying to do the same, and nowadays in the European Community 
there is a unified (although limited) system protecting patents (European 
Patent Convention (EPC) of October 5, 1973, in force in 1977)14 and 
trademarks (Council Regulation 40/94 of December 20, 1993).15 
So, the basic idea when thinking of IPR rights and its relation both to 
economic development and the activity of research and development is, 
as Christian Dambrini indicates, that: "globalization of economies cannot 
be effective without a strong, affordable, enforceable intellectual 
property rights system to protect its results.,,16 Therefore the challenge is 
10. SELECTED INTELLECfUAL PROPERTY AND UNFAIR COMPETITION STATUTES, 
REGULATIONS & TREATIES, SI. Paul, MN: West Publishing Company, at 390 (1997). It protects, 
among other things, the following works: Literary and artistic, derivative, and applied art and 
industrial designs. 
11. [d., at 805. This Convention was revised at Brussels on December 14, 1900, at 
Washington on June 2,1911; The Hague on November 6, 1925; London on June 2,1934; Lisbon on 
October 31, 1958; at Stockholm on July 14, 1967; and amended on October 2, 1979. The protection 
here is for patents, utility models, industrial designs, trademarks, services marks, trade names, 
indications of source or appellations of origin, and repression of unfair competition. 
12. Dunn, supra notel, at 161. "The GATT attempted to implement the first truly 
comprehensive intellectual property rights system. The TRIPS Accord includes plants IPRs in the 
form of patents, breeder's rights, or both, reflecting the northern view of ownership of plant 
genetics." 
13. SELECTED INTELLECfUAL PROPERTY AND UNFAIR COMPETITION STATUTES, 
REGULATIONS & TREATIES, supra note 10 at 822. The matter is regulated in Chapter 17 of the 
North American Free Trade Agreement, part SIX: Intellectual Property Chapter Seventeen: 
Intellectual Property. It regulates protection of, among others: copyright, sound recordings, and 
encrypted programs- carrying satellite signals, trademarks and patents. 
14. BERMAN ET AL., supra note 8, at 422. 
15. 1994 O.J (L 1111) (Jan 14, 1994). 
16. Christian Dambrini, Globalization of Research and Development: A Business Viewpoint 
in Facilitating International Technology Co-Operation Proceedings of the Seoul Conference, 
DSTIlSTPrrIP (97) 141FINAL, Mar. 28, 1999, at 27. Available at <http://www.oecd.orgldstilsti/U/ 
intelprod/seoul.htm>. 
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to ensure, as Joseph Villela concludes, that: "[a] all countries set high 
standards of intellectual property protection and enforcement in their 
national laws and effectively support and enforce the standards once the 
improved laws are in place; [b] all countries recognize the special 
intellectual property needs of industrial sectors whose inventions, 
because of regulatory requirements, reach the market place with 
considerable delay, after patent grant; and [c] that intellectual property 
protection is maintained and updated appropriately in today's rapidly 
changing technological world.,,17 
In order to ensure the worldwide protection of IPR and to minimize the 
risks related to lack of protection or enforcement of IPR, all developed 
nations have been developing a strong defense of these rights, and one 
example is provided by the posture of the U.S.A. The U.S.A. has been 
developing a great crusade in favor of the international and effective 
protection of IPR since the mid-1980s, which can be easily explained 
first because of the impact of infringements of IPR on American external 
trade, and second because of the economic importance Of the trade in 
intellectual property for American international trade (it represented $33 
billion in licensing fees and royalties in 1997).18 Today, as indicated by 
Benedicte Callan, it is on the top of the American agenda: "1. The full 
and timely implementation of TRIPs by all countries party to the WTO; 
2. The extension of TRIPs-level protection to countries not yet 
signatories to the WTO; 3. Adoption standards and enforcement 
mechanisms has to go beyond those contained in TRIPs; [and] 4. The 
expansion of protection to new issues through WIPO [World Intellectual 
Property Organization] or other multilateral agreements.,,19 
Finally, not only developed nations have been considering the protection 
of intellectual property as one of the most important elements in the 
protection of technology, but private companies are also sharing the 
same VIew. 
The IPR's connected with research and development in the field of 
biotechnology are usually protected by patents and plant breeders' 
17. Joseph F Villela, Intellectual Property Protection: a Business Viewpoint in Facilitating 
International Technology Co-Operation Proceedings of the Seoul Conference, DSTIlSTPfflP (97) 
141FINAL, Mar. 28, 1999, at 83. Available at <http://www.oecd.orgldstilstils_tI 
inte/prod/seoul.htIn> . 
18. Benedicte Callan, Intellectual Property Rights: Policies and Issues in the United States in 
Facilitating International Technology Co-Operation Proceedings of the Seoul Conference, 
DSTIlSTPfflP (97) 141FINAL, Mar. 28, 1999, at 110. Available at <http://www.oecd.orgldstilstil 
s_tlinte/prod/seoul.htrn>. 
19. [d., at 103. 
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rights.20 A patent is intended to protect a new, useful, and non-obvious 
process or product made by man, and these requirements are basically 
the same all over the world. However, the grounds for this protection 
may be different, depending on the country; some countries (like the 
USA)21 will apply a social and economic rationale in order to justify the 
protection of IPR, and others (like civil law countries, in general) will 
apply a natural-right theory. Independently of the theory applicable, the 
main issue will always be whether new forms of life can be considered a 
process and/or a product, thus leading to questions like whether man has 
a right over another life. Moreover, this discussion goes far as the 
protection of IPR occurs locally. Despite efforts to unify the protection, 
basically IPR is protected locally. This means that each local jurisdiction 
will grant protection according to its own law, and that protection can be 
granted by one country and refused by another. A good example of how 
the same patent can be seen in different countries is provided by the so-
called "Harvard Mouse": even though the Patent Trademark Office 
(USA) in 1988 issued the first patent concerning an animal, a transgenic 
mouse known as the "Harvard Mouse," Canada refused to do SO?2 
Plant breeders' rights (PBR),23 evolved by the International Union for the 
Protection of New Varieties of Plants (UPOV) Convention, are exclusive 
20. FAO, Intellectual Property Rights (last visited Sept. 15, 1999) 
<www.fao.orgidocrep/v4845e/v4845eOb.htm>. 
21. BARRET, supra note 7, at 93. In the USA, the monopoly conceded by the patent has as its 
objective to promote the progress of knowledge: :Jefferson's philosophy ... The patent monopoly 
was not designed to secure the inventor his natural right in his discoveries. Rather, it was a reward, 
and inducement, to bring forth new knowledge." 
22. Carrie F. Walter, Intellectual Property Law Review 1999, 31 INTELL. PROP. L. REV. 195, 
196 (1999). These different procedures adopted by countries suggest that "the debate about animal 
patenting is, indeed, unresolved and anything but clear cut." In the USA, besides the Harvard 
Mouse, there is also a patent granted to a bacterium capable of breaking down crude oil (Diamond v. 
Chakrabarty, 447 U.S. 303), and genetically engineered oysters (Ex Part Allen, 2 U.S.P.Q.2d (BNA) 
1425 (Bd. Pat. App. & Interferences 1987)), for example. 
The importance of the patent for biotechnology is well explained by Pauline Newman (in 
Pauline Newmany, Intellectual Property Law and the New Biology, 36 JUDGES J. 46, no. 3 (1997). 
Available in WESTLA W) when commenting on the decision in the case Diamond v. Chakrabarty, 
infra., she said: "This decision is credited with enabling the rapid growth of the biotechnology 
industry in the United States." 
23. FAO, Issues and Concerns in Biotechnology with Special Reference to Developing 
Countries (last visited Sept. 15, 1999) <www.fao.orgidocrep/v4845e/v4845e03.htm>. Even though 
there is a protection, the UPOY Convention adopts the fundamental principle of unrestricted access 
to genetic resources. 
Moreover, and according to Sara M. Dunn, supra note I, at 160: "there are three 
qualifications that a new variety must meet to receive protection under UPOY: (I) the new plant 
variety has to be clearly distinguishable from other varieties by one or more characteristics; (2) the 
new plant variety must be sufficiently homogenous in its sexual reproduction or asexual 
reproduction or asexual propagation; and (3) the new variety has to be stable in its essential 
characteristics. The UPOY's protection is limited in three different ways. First, the UPOV does not 
patent the new varieties; it only protects the breeder's rights to marketed varieties. This means that 
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and temporary rights granted by the government to plant breeders, 
allowing them to exclude others from producing or commercializing 
material of a specific plant variety.24 This right has been incorporated by 
local laws. An example here is the Brazilian Law 9456, de 25 de Abril 
de 1997, that regulates the IPR concerning a cultivar (a cultivated variety 
of a plant distinguished from other plants) - this law will be commented 
on later during the analysis of the Brazilian Case. Another example is 
the Plant Variety Protection Act (an American right, [hereinafter PVPAD 
establishing that "farmers may save new varieties of PVPA protected 
seed and use it for planting crops but cannot sell it as seed unless they 
have obtained the permission of the owner of the variety.,,25 
Concerning first the limits of the monopoly associated with the patent 
(the most important IPR in terms of technology), and second the rights to 
exclude others from producing or commercializing, associated with plant 
breeders' rights, the basic rule is that: although there is a protection, this 
monopoly/protection granted to the creator is granted for a determined 
period of time, and the creator must not abuse his/her rights. So, in the 
case of GMP the main refrain to the creator's action would be first the 
law, which means that he/she must avoid abuse of rights and he/she must 
also comply with other legal regulations concerning production, 
distribution, commercialization, consumer protection, and environment 
protection. A second refrain would be popular pressure by consumers or 
the general population, including boycott or negative market. A good 
example of the effect of popular 'pressure is the position adopted by 
Monsanto concerning the so-called "terminator technology" (or, sterile 
seeds) pursuant to such pressure.26 
new varieties may still be used by other res~archers for their own breeding purposes. Second, the 
UPOV incorporates the concept of "farmer's right." Farmers can reserve seed at harvest to use in 
planting the next year's crop but can not sell this seed to other farmers. Third, UPOV protection does 
not extend to the components chemicals of the plant." 
24. FAO, supra note 20. 
25. Neil D. Hamilton, Plowing New Ground: Emerging Policy Issues in a Changing 
Agriculture, 2 DRAKE 1. AGRIC. L. 181, 189 (1997). The Act is written in this way because of the 
decision by the U.S. Supreme Court in the case Asgrow Seed Co. v. Winterboer, 513 U.S. 179. In 
this case, the Supreme Court held that "farmers could not raise PVPA protected seed for the purpose 
of selling it to others." 
26. Barnaby 1. Feder, Monsanto Won't Market Sterile Seeds, S.F. CHRON., Oct. 5, 1999, C2. 
"[S]eeking to remove itself from one of the most inflamed debates in biotechnology, the Monsanto 
Co. said yesterday that it would make no effort to market seeds that produce crop plants that are 
themselves infertile. In the same matter, Dr. Melvin Oliver, a Department of Agriculture researcher 
in Lubbock, Texas, consider that "This [the position adopted by Monsanto] may be the right decision 
for Monsanto but I think abandoning the technology is a mistake ... seed sterility could be an 
important tool for making sure that other genetically engineered traits like herbicide resistance do 
not escape into wild plants." 
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Despite these concerns IPR has the important effect of stimulating the 
development of new process and products allowing the growth of 
industry in general; moreover, this kind of protection is essential in 
matters relating to high technology, such as biotechnology.,,27 But two 
questions remain: (a) Does this system protect less developed countries? 
and, (b) Does it promote general development or only create bases for 
the increase of technological or economic distance among countries? 
Although a clear answer does not exist, it is possible to infer from the 
view of less or least developed countries that this system works against 
less developed countries, allowing the increase of technological or 
economic distance among them and developed or developing countries, 
and perpetuating in this way their condition of dependency: "(M)ost 
developing countries, especially the least developed ones, have more 
need to absorb and diffuse as widely as possible the new technologies for 
their development. They try to avoid the overpricing and 
monopolization that could occur through imposition of strict IPR 
systems. Some even consider that the current international patent regime 
works to their disadvantage and that they receive nothing in return for 
protecting inventions produced in the developed countries.,,28 
As a matter of fact, nowadays countries can be classified not only as 
industrial, agricultural or service-based countries, but also as IPR's-based 
countries. The amazing thing is that whoever retains the IPR, and if this 
right is protected worldwide (it is not occurring at this moment, even 
though there are efforts in this vein), will be able not only to receive 
. royalties or to generate more new processes or products but also, and in a 
worst scenario, will be able to control the dissemination of technology 
and the production of services and goods in all the other countries. 
All these facts make clear the strong relationship between IPR and 
biotechnology, and also the strong relationship between 
IPRIBiotechnology and the world economy. 
2. Benefits, Risks and Safety 
As stated earlier, biotechnology today evokes both hope and fear. But 
what are the benefits and risks of biotechnology? 
27. Walter, supra note 22 at, 195. A patent "stimulates the growth of industry, and the 
industry of biotechnology welcomes any patent protection it receives." 
28. FAD, supra note 23. 
9
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The main benefits of biotechnology can be summarized in the following 
way: (a) it contributes to the human food supply and to the protection of 
biodiversity, allowing a more efficient use of land, and a more 
productive harvest;29 (b) it improves the quality of food;30 (c) it may 
contribute to reducing the use of agrochemicals31 and pesticide;32 and 
finally (d) it may be helpful for the maintenance of germplasm 
collections.33 
On the other hand, the risks associated with this activity can be divided 
and summarized into three categories: (1) risks to the economy; (2) risks 
to the environment, and (3) risks to the health. 
The main risks to the economy are well explained by Carrie Walter: 
"[S]mall farmers fear that a small number of large corporations will be 
able to corner the market on genetically engineered animals, thereby 
depriving the small family farms of their livelihood. Additionally, the 
farmers are concerned that the initial acquisition price of genetically 
altered animals, and the subsequent royalties, will increase rather than 
decrease the costs for farmers and consumers.,,34 
The main risks to the environment are the following: (a) the first risks are 
indicated by F AO in the following way "The inclusion of novel genes for 
herbicide resistance in plants may increase the occurrence of weeds with 
resistance to certain agrochemicals, the [F AO] reported warned. The 
29. Barton, supra note 5, at 99. "[TJechnology can contribute to the human food supply with 
less impact on biodiversity and world land use ... [and] can provide better foods by reducing post-
harvest crop loss to vermin and rodents and by improving nutritional quality." 
30. Walter, supra note 22, at 219. "Biotechnology holds the key to ... [improving] the quality 
of our food." 
31. FAO, Biotechnology Can Help Feed an Increasing World Population - Positive and 
Negative Aspects Need to Be Balanced, Press Release 99/2 (last visited Sept. 15, 1999) 
<www.fao.orglwaicentloislpress%FnelpressenglI999/pren9902.htm>. "The application of pesticides 
and fungicides could be reduced through plants with genetic pest resistance. Plants with tolerance for 
conditions of salinity or high iron toxicity could help to improve agricultural production in marginal 
areas." So, "biotechnology-derived solutions built into the genotype of plants could reduce use of 
agrochemicals, thus promoting sustainable yields." 
32. Michael A. Whittaker. Reevaluating the Food and Drug Administration's Stand on 
Labeling Genetically Engineered Foods, 35 SAN DIEGO L. REV. 1215 (1998). Available in 
WESTLAW: "transgenic plants containing natural insecticides may reduce the need for chemical 
pest control, benefiting the environment (which is now exposed to a barrage of harmful chemicals 
used in modern farming), farmers (who must now deal with an array of potentially harmful 
pesticides), and consumers (who ingest foods contaminated with pesticides residues). [Moreover] 
transgenic plants with increased resistance to herbicides may make it possible to use less toxic 
herbicides and increase crop yield." 
33. FAO Press Release 99/2, supra note 31. "[S]ome biotechnological techniques, like in vitro 
culture, are very helpful for maintenance of germplasm collections of species with low fertility and 
species that are hard to keep as seeds in field gene banks. " 
34. Walter, supra note 22, at 211. 
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inclusion of pest resistance in plants should be carefully evaluated for 
potential development of resistance in pests and possible side-effects on 
beneficial organisms.,,;35 (b) Michael Wittaker considers as a second risk 
the fact that "while crops may be engineered to contain natural 
insecticides, insects can adapt, becoming resistant much more quickly 
than expected. . .. The planting of crops containing herbicide resistance 
genes may, ironically, result in increased herbicide use, as farmers would 
be free to use herbicides to control weeds without fear of harming the 
crop plants themselves. Further, the crop plants may transfer these 
resistance genes to wild plants, potentially creating herbicide-resistant 
weeds that are a threat to the environment.,,;36 (c) The third risk is 
identified by John Barton, who says that: "the introduction of any new 
organism into an ecosystem might affect the dynamics of the ecosystem 
or the gene pool of wild relatives. These effects can happen whether the 
new organism is a new crop variety or a new microorganism introduced 
for disease control, and whether it is genetically-engineered, bred by 
traditional means, or simply from a different ecosystem.,,;37 (d) Finally, 
another risk is the loss of diversity38 provoked by the widespread use of 
one - or a few - species of crops. 
The main risk to health is allergy, and one example is found in the 
allergic side effects provoked by the addition of Brazil nut protein in a 
soybean.39 
Finally, is it safe to use GMP as food? A clear, conclusive, and well 
accepted answer does not exist: first because there is no scientific 
consensus;40 second, because the standards for evaluating the 
35. FAO Press Release 99/2, supra note 31. 
36. Whittaker, supra note 32, at 1220-1221. 
37. Barton, supra note 5, at 99. 
38. DAVID HUNTER ET AL,. INTERNATIONAL ENVIRONMENTAL LAW AND POLICY 934 (1998). 
"Biodiversity thus encompasses all of the variability among the building blocks of life (i.e., genetic 
diversity), different life forms (species diversity) and the interrelationship of life (ecosystem 
diversity). The concept of biodiversity does not discriminate between wild and domesticate animals 
and plants." The same author, on page 940, says, "in recent decades the trend in industrialized 
agriculture has been to plant ever more extensive fields of ever fewer varieties of these crops. Not 
only does the expansion of "monocultures" displace traditional varieties, but the lack of diversity 
makes crops highly susceptible to insects and diseases." 
39. Whittaker, supra note 32, at 1221. "[TJransgenic soybeans may be made more nutritious 
by the addition of Brazil nut protein, but to an individual allergic to Brazil nuts, consuming a food 
containing this protein may present a life-threatening situation." 
40. Professor Liam Donaldson and Sir Robert May, Health Implications of Genetically 
Modified Foods, Department of Health, May 1999 (last visited Sept. 20, 1999) 
<www.doh.gov.uklgmfood.htm>. The Department of Health in the United Kingdom, in a study 
prepared May 1999, concludes among other things that: "many of the issues raised by foods 
resulting from genetic modification are equally applicable to foods produced by conventional means 
. . . . There is no current evidence to suggest that the GM technologies used to produce food are 
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consequences of a GMP used as a food vary from country to country;41 
and finally, because social and cultural aspects also influence the 
answer.42 The actual fact is that nowadays there is a lot of "unsafe" food 
lawfully in the market, and one example here is the productSweet'n Low, 
a sugar substitute commercialized in the USA by Cumberland Packing 
Group. The label of this product provides the following warning: "[u]se 
of this product may be hazardous to your health. This product contains 
saccharin which has been determined to cause cancer. in laboratory 
animals." 
Thus in evaluating the riskslbenefits of GMP it seems that the crucial 
element is the impact of GMP on the environment instead of its impact 
on individual health. 
B. GMP AND COMMERCE 
Here four questions will be answered: who are the producers? What is 
the position of the USA and the European Union? What are 
intergovernmental organizations and NGOs doing? Should developing 
countries be producers? 
1. Who Are the Producers? 
Nowadays about 2.5 billion people have been eating GMP directly or 
indirectly, knowingly or not. Moreover, the number of consumers is 
expected to increase, just because: (a) multinationals have been investing 
billions and billions of dollars in new products,43 and (b) each day more 
inherently harmful. . . . [N]olhing can be absolutely certain in a field of rapid scientific and 
technological development .... " 
41. Dunn, supra note 1, at 154, 166. "Allergic reactions could occur in humans from 
inadvertent transferring of proteins during lhe genetic engineering process. The allergenic potential 
for GMOs is largely unknown, yet US government officials are joining lhe seed companies in 
claiming that these products are safe . . . [concerning) the evolution of resistant plants and insects 
from overuse of genetically modified seed ... laboratory experiments and field trials have failed to 
produce [lhe insect European Com Borer) EC Borer that are resistant to Bt com, but growers as still 
advised to plant twenty-five percent of their acreage to non-Bt com varieties ... [concerning) the 
loss of biodiversity ... biodiversity needs to be protected and preserved for its intrinsic value as well 
as its economics values ... biotechnology will provide necessary tools for the twenty-first century." 
See generally Barton, supra note 1 at 106. Bt means "Bacillus thuringiensis [a) genes or 
virus coat protein lhat confer resistance to respective categories of insects or viruses." 
42. Marsha A. Echols, Food Safety Regulation in the European Union and the United States: 
Different Cultures, Different Laws, 4 COLUM. J. EUR. L. 525 (1998). Available in LEXIS: This 
author provides a good analysis of the influence of culture in biotechnology issues. 
43. 0 GLOBO ON - Vanice Cioccari, A nova Revolur;iio Transgencia da Agricultura (last 
visited Aug. 30, 1999) <www.ogiobo.com.br/arquivo/cienciaJI9990704/civilO.htm>. 
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countries are allowing cultivation of GMP, in a market that will reach 
US$ 500 billions/year in the next few years.44 
The table below, translated from an article available in C&T Brasil,45 
shows which countries have already authorized the harvest of GMP: 
Country GMP commercialized I Beginning of Commercialization 
Argentina soy11996, cornl1998, cottonll998 
Brazil None ** 
Canada com11998, cottonll996, canolal1997, MELAOI1998, potato/1999, 
wheatl1999 
EUA MELA0I1994, soy/1994, tomatol1994, cottonl1994, potatoll994, 
canolal1995, cornl1995 
Japan soy1l996, canolal1996, potatol1996, cornl1996, cottonl1997, 
tomatoll997 
EU Tomato/1995, canolall995, soy1l996, cornl1997, potatoll998, 
cottonll998. 
** It had gIven authonzatlOn to Monsanto to commercIalIze soy, but thIS authonzatlOn 
was revoked by a judicial decision (See in this paper the topic "The Brazilian Case"). 
Moreover, it is clear that transgenic soybeans have been developed in Brazil and, at least 
in one case, this product, according to Michael Whittaker, provoked allergy. 
Even though not mentioned in the table above, China is one of the largest 
producers, together with Canada, Argentina and the USA, and among 
these producers the USA is the largest.46 As a matter of fact, according 
to Charles Margulis, a genetic engineering campaigner for Greenpeace, it 
is estimated that "75 percent of all bio-engineered crops are grown in the 
U.S. [moreover, and according to Mothers for Natural Law] 60 to 70 
percent of foods on U.S. grocery store shelves contain genetically 
engineered substances. ,,47 
44. [d. Moreover, in the same article, the position and the importance of GMF for the USA is 
summarized in the following way: "USA has been cultivating GMF since 1994, and last week, Stuart 
Eizenstat, from the US Treasury Department, said that almost 100% of the agricultural products 
exported by USA in the next five years will be genetically modified or products combined with 
them." 
45. C&T Brasil, Percepr;iio Publica da Biotecnologia (visited Sept. 9, 1999) 
<www.mct.gov.br/ctnbioteclpercep.htm>. CTNBio showed this table in an article supporting its 
decision in authorizing the exploitation of the Soy Roundup Ready by Monsanto in Brazil. 
46. FAO Report, Technical Meeting on Benefits and Risks of Transgenic Herbicide Resistant 
Crops, Rome, Italy, 16-18 Nov. 1998 (last visited Oct. 27, 1999) 
<www.fao.orgIWAICENTIFAOINFOIAGRICULT/magazine/default.htm>. 
47. CNN.com, supra note 3. 
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2. The Commercial Battle: The Positions of the USA and the EU 
The qilestion is: Why the USA and the EU? The answer is simple: in 
1997 the USA was the main importer of agricultural products (excluding 
fish) in the world, and in the same year seven out of the ten most 
important importers of agricultural products (also excluding fish) were 
members of the EU: France, Germany, Italy, Spain, the United Kingdom, 
Belgium, and the Netherlands.48 So, if they are the most important 
importers, the perception that they have concerning biotechnology and its 
application to agriculture will have a great impact in terms of acceptance 
of this technology by other potential producer countries, and their views 
concerning the issue are completely different. 
If it is clear that there is a high standard of protection of consumers' 
rights and consumers' health, it is also clear that they have a different 
way of approaching this matter, for example: (a) in the USA, GMP will 
be considered safe,49 unless there is actual proof against this assumption, 
and if the GMP is safe, the food is also safe and there is no need for 
special label indicating that the food originated from GMP.50 On the 
other hand, the position in EU is that the GMP and its products are 
48. FAOSTAT Agriculture data, Food Excl Fish Imp Val at Base Yr Price (/000$) (last visited 
Oct. 27, 1999) <apps.Fao.orglcgi-binlnph-db.pl?subset=agriculture>. 
49. Echols, supra note 42, at 537. "The fundamental concept underlying the regulatory 
scheme is that foods derived from new plant varieties are like any other foods and are safe." 
50. Judith E. Beach, No "Killer Tomatoes:" Easing Federal Regulation of Genetically 
Engineered Plants, 53 FOOD DRUG L.1. 181, 182 (1998). Available in LEXIS: "most federal 
agencies and officials now take the position that there is no difference between genetically modified 
and traditional food crops, and therefore biotechnology foods requires no special labeling unless 
specific safety issues are raised. Indeed, the U.S. government objects to the European Union's (EU's) 
special labeling of genetically altered foods as unwarranted and scientifically irrational." 
See also CNN.com, supra note 3. "To date, the U.S. Food and Drug Administration has 
not required testing of any OM foods, stating they are not aware of any information showing that 
OM foods differ from any other foods. " 
Moreover, the process of approval in the United States is well explained by Sara M. Dunn, 
supra note 1, at 152: "genetically enhanced crops such as Bt com and Round ready soybeans require 
approval of the US Environmental Protection Agency (EPA), the FDA, and the USDA before they 
can be market. A company developing a genetically engineered plant must obtain a permit from the 
USDA to begin field testing. Field testing is necessary to detennine whether the plant will perform 
in the natural environment in a manner similar to that of the laboratory trials. After field tests are 
complete, the company may apply for the plant to be exempted from further USDA regulations and 
approved for commercial use. After the USDA has approved the plant the FDA and the EPA become 
actively involved. The FDA ensures that all new food products are safe. The EPA reviews the 
product to detennines whether unintended negative impacts on the environment or other organisms 
would result." 
And finally, this process in the view of Philip S. Angell (Director, Corporate 
Communications MONSANTO Company) "is doing quite well." Moreover, he also said that: "It is 
because of that track record, and because our system remains flexible, that we should be wary of any 
proposal for radical change." Forum, How Should We Regulate Biotechnology in Agriculture?, 16 
ENVTL. FORUM 48 No.2 (MAR.! APR. 1999). 
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considered unsafe, unless there is clear proof against this assumption, 
and if the food is not safe "a priori" the consumer must be protected 
through a speciallabel;51 and (b) in the words of US Ambassador David 
Aaron, Under Secretary for International Trade U.S. Department of 
Commerce, in the USA the process is more science-based while in 
Europe this process is driven by political pressure, and it makes the 
process in Europe slow and non-transparent. 52 In the same way Dan 
Glickman, Secretary of Agriculture in the USA, emphasizes that "We 
[USA] base decisions on rigorous analysis and sound scientific 
principles. ,,53 
Marsha Echols comments on these differences saying that: "while 
Europe supports traditional processes, often it struggles in developing a 
food safety policy toward new or "novel" products and technologies ... 
the U.S. usually is more receptive to both . .. [another distinction] 
philosophically, the U.S regulatory approach permits a great deal of 
industry self-regulation, while Europeans usually adopt a more detailed 
regulatory scheme.,,54 
These approaches: (a) first reflect the way through which GMP and its 
products are analyzed for approval (or not) in both areas, as explained by 
Terence Stuart and David Johanson: "the United States has an 
established regulatory system for approval of genetically modified 
organisms (GMOs), which makes the process of introducing a 
genetically modified food or agricultural product into the market fairly 
51. Terence P. Stuart and David S. Johanson, Policy in Flux: The European Union's Laws on 
Agricultural Biotechnology and Their Effects on International Trade, 4 DRAKE J. AGRIC. L. 243 
(1999). Available in IEXIS: "Under Article 16 a member state may "provisionally restrict" a GMO 
approved for sale under Directive 9012201EEC if the state has "justifiable reasons" to believe that the 
product might adversely affect human health or the environment. . .. The Commission's original 
proposal for the mandatory labeling legislation for the relevant GMO maize and soya provided that 
in cases in which it is uncertain as to whether a product contains these GMO products, the label 
should state 'may contain GMOs.' ... Regulation No. 1139/98 requires that products containing 
DNA or protein resulting from genetic modification of the relevant GMO soya and maize be labeled 
as "genetically modified," or produced through genetic modification .... The regulation does not 
provide for the "may contain" labeling option for products for which it is not possible to determine 
whether they contain the relevant GMOs." 
52. Prepared Statement of Ambassador David L. Aaron, Under Secretary for International 
Trade U.S. Department of Commerce, before the U.S. House of Representatives - Committee on 
International Relations, June 15, 1999 (last visited Nov. 2, 1999) 
<www.ogc.doc.gov/ogcllegregltestimonll06f/aaron0615.htm>. 
53. The United States Mission to the European Union, Glickman on Hormone Beef and 
Biotechnology. Remarks as Prepared for Delivery by Secretary of Agriculture Dan Glickman before 
the National Press Club on New Crops, New Century, New Challenges: How will Scientists, 
Farmers, and Consumers Learn to Lave Biotechnology and What Happens if they Don't?, July 13, 
1999 (last visited Nov. 2,1999) <www.useu.be/issues/glick0715.html>. 
54. Echols, supra note 42, at 533. 
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predictable ... [on the other hand] few Europeans appear satisfied with 
the European Union's laws in this area. Consequently, these laws are 
frequently changing and will likely continue changing in the foreseeable 
future. This legal uncertainty significantly impacts U.S. agricultural 
producers seeking access to the European market,,;55 (b) second reflect a 
different level of technology applied in the agricultural process in both 
areas, as commented by Luiz Barret: "it is not amazing that Europeans, 
who practice an agriculture not competitive, and dependent on 
chemicals, be against biological solutions;,,56 and, finally, (c) they reflect 
the position of the consumers. Terence Stuart and David Johanson 
summarized the position thus: "while the introduction of genetically 
modified food products into the U.S. market has been challenged by 
consumers' groups on grounds of possible health risks, the use of 
biotechnology appears accepted by the American public .... In contrast, 
the sale and cultivation of GMO agricultural products in the European 
Union has been and continues to be heavily contested by consumers." 57 
However, the acceptance by American people does not overrule the right 
of information: 85% of Americans considered the labeling of GMF very 
important, according to the United States Department of Agriculture, and 
99% desire a clear identification in the label indicating that the product is 
aGMF.58 
These facts show clearly that EU and USA have different positions 
concerning GMP, and also show that differences in culture, and 
differences in economic organization, are the main reasons for that. As a 
consequence of these differences, measures such as moratorium, ban, or 
label requirements have been taken by the EU or by some of its 
members, and the result of this action, as per the view of the USA, is first 
the impairment of the free trade concept, with violation of the rules set in 
out the GATT Agreement, and second direct damage to America's 
farmers harvesting this kind of crop. 
But what are the roles of international organizations and NGOs on this 
issue? 
55. Stuart, supra note 51 at 246, 247. 
56. Vannildo Mendes, Brasil pode Restringir a Produr;:iio e 0 Consumo dos Alimentos 
Transgenicos, 0 GLOB a ON (last visited Aug. 3D, 1999) 
<www.oglobo.com.br/ciencia/cividlO.htrn>. It was the opinion of Luiz Antonio Barret, the former 
president of CTNBio in Brazil. The original text in Portuguese is: "Niio e supreendente que os 
europeus, que praticam uma agricultura sem competitividade international, dependente de insumos 
qufmicos, sejam contranos a solu,<Oes biologicas." 
57. Stuart, supra note 51, at 246. 
58. IDEC, 0 Risco dos Alimentos Geneticamente Modificados, (last visited Sept. 9, 1999) 
<www.uol.com.br/idec/campanhaslbio2_novo.htrn>. 
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3. The Role of Intergovernmental Organizations (lOs) and NGOs 
On October 12, 1999, the total population in the world reached six 
billion, six times the total population in 1804, and 60% of the total 
population expected by 2050.59 This fact together with the evolution of 
technology, dissemination of information, development of international 
organizations acting in protecting the environment, and economic 
globalization,60 has been increasing the importance of questions relating 
to environment and sustainability of life on the earth. 
Moreover, this evolution of environmental concerns, and the forces 
relating to it, have provoked different reactions in society, and these 
different reactions may well be seen through the position concerning the 
GMP adopted by lOs and NGOs. The positions adopted by the Food and 
Agriculture Organization (FAO), by the Organization for Economic Co-
operation and Development (OECD), and by Greenpeace, deserve 
attention and the reasons can be explained in this way: (a) FAO deserves 
comment first because its activity is connected with environmental 
conditions,61 second because the matter of GMP is directly linked with 
this organization, third because this organization has been developing a 
close relationship with other organizations,62 and finally, because its 
59. And Baby Makes 6 Billion, S.F. CHRON. (East Bay Edition), Oct. 10, 1999, at AI. 
60. Lynton K. Caldwell, Is World Law an Emerging Reality? Environmental Law in 
Transnational World, 10 COLO. J. INT'L ENVTL. L. & POL'y 227 (1999). 
61. Id., at 231. "The intergovernmental organizations that are concerned with environmental 
affairs are largely associated with the United Nations: the Specialized Agencies; the Food and 
Agriculture Organization; the World Health Organization; the World Meteorological Organization; 
the United Nations Educational Scientific and Cultural Organization; the World Bank; the United 
Nations Environmental Programme; the Commission on Sustainable Development; and bodies 
subsidiary to one or more of these agencies, such as the Global Environmental Facility. Regional 
intergovernmental organizations such as the Organization for Economic Cooperation and 
Development, the Organization of American States, the Organization of African Unity, and the 
European Union also have environmental agencies andlor agendas." 
62. Some examples of this cooperation are found in FAO, Biotechnology in Agriculture, 
Forestry and Fisheries: FAO Policies and Strategies, (last visited Sept. 15, 1999) 
<www.fao.org.sdlrtdirectlrtreOOO1.htm>: "FAO will continue to cooperate with United Nations 
Industries Development Organization (UNIDO), UNEP and WHO in the establishment of codes and 
guidelines for biotechnology-related environmental and health risk assessment. The 
UNIDO/UNEPIWHOIFAO Working Group on Biosafety brought out a Voluntary Code of Conduct 
for Release of Organisms into the Environment in 1991 ... FAO has been collaborating with several 
UN and non-UN agencies/systems in a number of activities related to biotechnology. For instance, it 
takes part in the UNEP-initiated effort to establish a Convention on Biodiversity and in the 
Biotechnology Working Group formed in that effort. FAO was a member of the Working Group on 
Biotechnology which was created in preparation for the 1992 UN Conference on Environment and 
Development (UNCED), and will continue to work with other UN Agencies in implementing the 
Action Plan on Biotechnology contained in UNCED Agenda 21. The Organization has been working 
with UNIDO, UNEP and WHO in developing a Code of Conduct for Biosafety, and in developing 
food safety standards. It will continue to work closely with WIPO and GAlT in evolving 
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status is not only local or regional, but international, as a specialized 
agency of the United Nations. (b) OECD deserves comment because 
OECD countries (only 29 members) produce two thirds of the world's 
goods and services,63 and (c) Greenpeace deserves comment not only 
because it is one of the most well known and respected NGOs in the 
world, but also because it plays a key role in the Brazilian Case, which 
will be discussed in this paper. 
FAO was founded in October 1945 having as one of its goals: to "raise 
levels of nutritive and standards of living, to improve agricultural 
productivity, and to better the conditions of rural populations.'M The 
role developed by F AO for GMP can be summarized as follows: First, 
FAO acts as a special forum where matters relating to food and 
agriculture are discussed. 65 Two good examples of the results of these 
discussions are the preparation of the Report on the State of World's 
Plant Genetic Resources for Food and Agriculture (prepared for the 
International Technical Conference on Plant Genetic Resources -
Leipzig, Germany (June 17-23, 1996), and the Reporter of the 
Commission· on Genetic Resources for Food and Agriculture (prepared 
during the Eighth session in Rome, April 19-23, 1999), where FAO 
analyzed the Global Plan of Action for the Conservation and Sustainable 
Utilization of Plant Genetic Resources for Food and Agriculture adopted 
in the Leipzig Conference.66 In these documents FAO recognizes among 
other things that: 
appropriate intellectual property protection systems suitable for both developed and developing 
countries .... " 
63. OECD, What is OECD, (last visited Oct. 29, 1999) 
<www.oecd.orglaboutlgeneralfindex.htm>. The members are: Australia, Canada, Finland, Greece, 
ireland, Korea, The Netherlands, Poland, Sweden, United Kingdom, Austria, Czech Republic, 
France, Hungary, Italy, Luxembourg, New Zealand, Portugal, Switzerland, the United States, 
Belgium, Denmark, Germany, Iceland, Japan, Mexico, Norway, Spain, and Turkey. 
64. FAO, What .it Is, What it Does, (last visited Oct. 29, 1999) 
<www.fao.org/UNFAOIWHATITIS.htrnI>. 
65. /d. More than act as a forum for debate, FAO also "offers direct development assistance, 
collects, analyses and disseminates information, provides policy and planning advice to governments 
" 
66. FAO, Report on the State of the World's Plant Genetic Resources for Food and 
Agriculture - Prepared for the International Technical Conference on Plant Genetic Resources, 
Leipzig, Germany, June 17-23, 1996, at 6, 8, 13, 15 (last visited Sept. 16, 1999) 
<web.Icppgr.fao.orglwrlmap_e.htm>. "The conservation and sustainable utilization of plant genetic 
resources is key to improving agricultural productivity and sustainability thereby contributing to a 
national development, food security, and poverty alleviation ... Historically, plant genetic resources 
have contributed to stability in agro-ecosystems and provided the crucial raw material for the rise of 
modem scientific plant breeding ... Many plant genetic resources which may be vital to future 
agricultural development and food security are threatened today. Country Reports indicate that 
recent losses of diversity have been large, and that the process of "erosion" continues ... The chief 
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(a) the sustainable use of plant genetic resources is essential for 
increasing agricultural productivity, and this fact can contribute 
not only to food security but also to natural development, 
allowing both the alleviation of poverty and starvation;67 
(b) modem agriculture is the most important cause of loss of 
genetic diversity, and the loss of diversity increases the possibility 
of crop losses; 68 and 
(c) much needs to be done, and done locally, moreover; in the 
long term the preparation of a Report on the State of Agricultural 
Diversity should be considered.69 
Second, FAO works in order to establish food standards, including 
recommendations for food labeling, food additives, and pesticide 
residues. An example here is the so-called Codex Alimentarius, 
developed by the FAO together with the World Health Organization 
(WHO), establishing more than 200 standards.7o In terms of labeling, 
F AO also recognizes that a label is a way for allowing a proper choice of 
contemporary cause of the loss of genetic diversity has been the spread of modem agriculture. The 
largely unintended consequence of the introduction of new varieties of crops has been the 
replacement - and loss - of traditional, highly variable farmer varieties ... The concomitant increase 
in uniformity may also lead to greater risk and uncertainty. The US National Academy of Sciences 
described genetic vulnerability as "the condition that results when a widely planted crop is uniformly 
susceptible to a pest, pathogen or environmental hazard as a result of its genetic constitution, thereby 
creating a potential for widespread crop losses." 
67. [d. 
68. /d. 
69. FAO, Report of the Commission on Genetic Resources for Food and Agriculture (Eighth 
Session) Rome, April 19-23, 1999, at 3, 4 (last visited Sept. 16, 1999) 
<www.fao.orglWAICENTIFAOlNFO/AGRICULT/cgrfa/docs8.htm: FAO analyzed the Global Plan 
of Action for the Conservation and Sustainable Utilization of Plant Genetic Resources for Food and 
Agriculture, adopted in Leipzig, Germany, in June 1996, and concluded basically that: "while there 
had been significant progress, much remains to be done at local, national, and international levels ... 
The Commission recognized the need to develop mechanisms for early warning on threats to plant 
genetic resources, and to increase capacities to promote the regeneration of plant genetic resources .. 
. . It was suggested that, in the longer term, a Report on the State of Agricultural Biodiversity might 
be envisaged .... " 
70, FAOIWHO, Codex Alimentarius, (last visited Sept. 15, 1999) 
<www.fao.orglnews/1999/codex-e.htm>.This Code is "a compilation of all Standards, Codes of 
Practices, Guidelines and Recommendations of the Codex Alimentarius Commission ... The Codex 
adopts international recommended standards, guidelines and codes of practice after thorough 
consideration by the Codex member countries. The Codex Alimentarius contains more than 200 
standards. There are general standards or recommendations for: food labeling; food additives; 
contaminants; methods of analysis and sampling; food hygiene; nutrition and foods for special 
dietary uses; food import and export inspection and certification systems; residues of veterinary 
drugs in foods; and pesticide residues in foods." 
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food by consumers.71 Finally, FAO recognizes that even though 
biotechnology is a powerful instrument to increase the world's of food 
supply, it has positive and negative aspects that must be carefully 
considered,n and each country is responsible for making this decision.73 
OECD came into being in September 1961, superseding the Organization 
for European Economic Cooperation (OEEC) created on April 16, 
1948,74 and its main objectives include: the development of sustainable 
economic growth and employment, the expansion of economic trade on a 
non-discriminatory basis, and the allowance of cooperation among its 
members. 
Biotechnology is not a new subject in OECD. Since 1980 this matter has 
been discussed by OECD, and as a consequence of the discussion, in 
1982 OECD published "Biotechnology: International Trends and 
Perspectives," containing a number of recommendations, including one 
stating that governments must have mechanisms regulating the safety of 
products of modern biotechnology. In 1986 another publication, 
"Recombinant DNA: Safety Considerations," also known as "1986 Blue 
Book," dealt specifically with genetic engineering.75 In 1992 the first 
commercial approval took place (in the USA - a member of OECD), and 
in 1993 an Internal Co-ordination Group for Biotechnology was 
established in order to coordinate· and facilitate cooperation among 
various directorates dealing with biotechnology, including the 
Environment Directorate, the Directorate for Science, Technology and 
Industry, and the Agriculture Directorate.76 
71. FAO, Understanding the Codex Alimentarius -- Codex and Consumers, (last visited Sept. 
15, 1999) <www.fao.org/docrep/w9950e/w9114e05.htm>. The food labeling provides "the consumer 
with information about a food so that a wise choice of food can be made." 
72. FAO (Press Release 99/2), supra note 31. "Biotechnology is a powerful tool to feed an 
increasing world population, but its 'positive and negative potential' should be carefully evaluated .. 
. All concerns must be clearly balanced, respecting ethical aspects but reflecting the actual and 
potential possibilities of increasing food supplies and alleviating hunger .... " 
73. FAO, supra note 62: "Each country has a responsibility to formulate its own policies, 
priorities, strategies and programmes for harnessing biotechnology, and to weigh expected benefits, 
not only against possible negative effects but also against the risk of not exploiting the technology .. 
. [and] on request, FAO can provide technical inputs to assist in planning, programming, priority 
setting and strategy formulation." 
74. About OECD - OECD Origins, (last visited Oct. 29, 1999) <www.oecd.org/aboutl 
origins/oeec.htm>. 
75. OECD OBSERVER, The Core of the Matter, Issue no. 216 (last visited Oct. 25, 1999) 
<www.oecd.org/publications/observer12l6/e-toc.htm>.This publication, as stated in OECD 
Observer, "put forward key safety concepts for development and commercialization of GMOs 
[genetically modified organisms], including genetically modified plants for agricultural use." 
76. OECD OBSERVER, Biotechnology at the OECD, Issue no. 216 (last visited Oct. 25, 1999) 
<www.oecd.org/publications/observer12l6/e-toc.htm>. See also OECD at Work - OECD Main 
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OECD recognizes that the matters relating to biotechnology are growing 
in terms of public debate:77 (a) first, OECD recognizes that the concept 
"substantial equivalence,,78 is a useful tool when dealing with food and 
biotechnology, even though it "cannot always be readily established;,,79 
(b) second, in a consensus document (on rape-seed oil) OECD also 
recognizes that genetically modified organisms impact the environment, 
but this "impact can differ from one place to another - the actual 
assessment itself remains the responsibility of the national authorities 
themselves to carry out,,;80 (c) third, OECD recognizes that "liberalizing 
trade policy will expand the volume of agricultural trade and alter 
regional productions patterns, but it will most likely not produce 
significant environmental effects.,,81 (d) fourth, OECD member countries 
recognize the need to harmonize regulatory approaches in terms of 
products of biotechnology "in order to avoid unnecessary trade 
barriers,,;82 and (e) finally, Donald Johnston, Secretary-General, in an 
editorial for OECD Observer, recognizes first that "traditional agriculture 
practices are polluting. In contrast, cultivation using biotechnology can 
reduce pollution," and second that biotechnology is essential for "making 
a transition to a sustainable world economy [and concludes by saying 
that] like it or not, it is irreversible." 83 
Just because biotechnology is considered essential, OECD is intensifying 
its work on biotechnology and, at the request of the G-8 countries, has 
invited NGOs for consultation on November 20, 1999, in preparation for 
their next summit meeting in July 2000.84 
Activities, <www.oecd.org/aboutlworklindex.htm> for a summary of the activities of the following 
Directorates: Environment, Agriculture, and Science, Technology and Industry. 
77. OECD OBSERVER, supra note 75. 
78. Greenpeace, Nature Article Condemns GE Food Regulation as "Pseudo-Science," (last 
visited Oct. 24, 1999) <www.greenpeace.org/-geneng/>: "The concept of substantial equivalence 
embodies the idea that existing organisms used as foods, or as sources of food can be used as the 
basis for comparison when assessing the safety of human consumption of a food or food component 
that has been modified or is new." 
79. OECD OBSERVER, GM Food, Regulation and Consumer Trust, Issue no. 216 (last visited 
Oct. 26,1999) <www.oecd.org/publications/observerI216/e-toc.htm>. 
80. OECD OBSERVER, What is Harmonisation of Regulatory Oversight?, Issue no. 216 (last 
visited Oct. 25, 1999) <www.oecd.org/publicationslobserverI216/e-toc.htm>. 
81. Agriculture and Environment - The Environmental Effects of Reforming Agricultural 
Policies, (last visited Oct. 29,1999) <www.oecd.org/agrlNews/cont-1.htm>. 
82. Environment Directorate, Consensus Document on General Information Concerning the 
Genes and Their Enzymes that Confer Tolerance to Glyphosate Herbicide, ENV/JMlMONO (99) 9, 
Paris 1999. 
83. OECD OBSERVER, A Defense of Modem Biotechnology, by Donald J. Johnston, Issue no. 
216 (last visited Oct. 25, 1999) <www.oecd.org/publications/observer/216/e-toc.htm>. 
84. OECD Online: Biotechnology & Food Safety, NGO Consultation Meeting, (last visited 
Oct. 30, 1999) <www.oecd.org/subjectlbiotechlngoconsultation.htm>. 
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But what is the role of NGOs? 
With regards to NGOs, the best known and organized in this field is 
Greenpeace.85 It has acted in a very organized way in order to ban GMP, 
especially in Europe (and now in Brazil) where the public is more 
receptive to this idea. It has basically two areas of action: first, to 
publicize some issue, informing the general public that the issue exists, 
and second, to put together individual voices in order to create an 
effective pressure group. And the pressure works. 86 
The position of Greenpeace can be summarized in the following way: (a) 
Greenpeace considers inappropriate the application of the principle of 
"substantial equiValence," usually adopted not only by OECD but also by 
other defenders of GMP;87 and (b) Greenpeace considers that the 
application of the precautionary principle is appropriate.88 
An issue today is that the works of some intergovernmental organizations 
are not transparent to NGOs (GATT, for' instance), even though NGOs 
currently have an observer status in the Montreal Protocol, Basel 
Convention, and Framework Convention on Biological Diversity.89 The 
fact is that, because of its influence, NGOs are more and more involved 
with lOs, and the invitation by OECD, mentioned above, is a good 
example. The only problem is that the involvement, if really close, may 
destroy the most important characteristics of NGOs: independence and 
credibility. 
85. How Greenpeace Works, (last visited Oct. 29, 1999) <www.greenpeace.org/report98lhtmll 
contentlworks.html>: "Greenpeace is a global environmental campaigning organization ... [and] 
organizers] public campaigns for the protection of oceans and ancient forests, for the phasing-out of 
fossil fuels and the promotion of renewable energies in order to stop climate change, for the 
elimination of toxic chemical, against the release of genetically modified organisms into nature and 
for nuclear disarmament and an to nuclear contamination." 
86. CNN.Com, Gerber Ends Use of GM Ingredients, (last visited Sept. 2, 1999) 
<cnn.ComINATUREl9908/04/gerber.enn>. This material provides some examples: (a) in July 1999 
Gerber, "the United States' largest producer of baby food, has decided to stop using genetically 
modified corn, soy and other foods in their baby food products . . . [and the reason for that was 
probably an] action by Greenpeace ... ;" (b) Another victory, "last summer, Greenpeace confronted 
Novartis about the presence of bio-engineered ingredients in their Galactina line of baby food sold in 
Switzerland. As a result, Novartis removed many products lines from the Swiss grocery stores and 
made a promise to remove genetically modified ingredients from the Galactina foods." 
87. Greenpeace, supra note 78. Greenpeace received great help from the scientific journal 
NATURE which published on October 7, 1999 an article indicating that the concept of "substantial 
equivalence" "lacks a usable definition." 
88. Greenpeace, OUT OF THE MAIZE, (last visited Oct 29, 1999) in 
<www.greenpeace.org/report98lhtmllcontentlgeneng.html>. 
89. Kevin C. Kennedy, The Illegality of Unilateral Trade Measures to Resolve Trade-
Environment Disputes, 22 WM. & MARY ENVTL. L. POL'y REv. 375,423 (1998). 
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Considering the important role reserved for lOs and NGOs, the 
conflicting position between the USA and EU, and the fact that the USA 
and the EU are great consumers of agricultural products, the question 
now is: what position should a producer (in this case a developing or an 
undeveloped country) adopt? The Brazilian Case commented upon 
below will give some hints about how these questions can be answered. 
4. Should Developing or Undeveloped Countries be Producers? (The 
Brazilian Case) 
The Brazilian Case shows clearly what kind of pressure a country will 
encounter, and what kind of decision a country will need to take. Brazil 
is presently among the most important economies in the world, and its 
agricultural sector is responsible for 14% of its GDP.9o The main 
agricultural products exported by Brazil are coffee, soybeans, and sugar 
cane.91 Soybeans are responsible for US$5 billion in export, and it is 
exported basically to Japan (US$1.5 billion), and to EU (US$2.5 
billion).92 Traditionally, the main commercial partners of Brazil are the 
EU and U.S.A.93 
Environmental matters in Brazil are considered constitutional matters, 
and can be regulated not only by local government, but also by the 
federal government. In fact, the Brazil Constitution provides among 
other things that: (a) "Article 23. The Union, the states, the Federal 
District, and the municipalities, in common, have the power: ... VI - to 
protect the environment and to fight pollution in any of its forms; VII -
to preserve the forests, fauna and flora;" (b) "Article 24. The Union, the 
states and the federal District have the power to legislate concurrently 
on: . . . VI - . . . preservation of nature . . . protection of the 
environment ... ;" and (c) "Article 225 ... § 1 ... it is incumbent upon 
the Government to: ... II - ... preserve the diversity and integrity of 
the genetic patrimony of the country and to control entities engaged in 
research and manipulation of genetic material; . . . IV - demand, in the 
manner prescribed by law, for the installation of works and activities 
which may potentially cause significant degradation of the environment, 
a prior environmental impact study, which shall be made public; V -
90. CIA. The World Factbook 1999 - Brazil (last visited Oct. 25, 1999) 
<www.odci.gov/cia/publicationslfactbook/br.htm1>. 
91. THE WORLD ALMANAC AND BOOK OF FACfS 1999, World Almanac Books, New Jersey, 
770 (1998). 
92. 0 GLOBO ON, supra note 56. 
93. THE WORLD ALMANAC AND BOOK OF FACfS 1999, supra note 89: "Imports (1996): $53.3 
bi); partners: EU 26%, U.S. 24%. Exports (1995) $46.5 bi); partners: EU 28%, U.S. 17% .... " 
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control the production, sale and use of techniques, methods or substances 
which represent a risk to life, the quality of life and the environment; ... 
vn - protect the fauna and the flora, with prohibition, in the manner 
prescribed by law, of all practices which represent a risk to their 
ecological functions, cause the extinction of species or subject animals to 
cruelty.,,94 
According to its Constitution and following international trends 
established by international Conventions, including the Convention on 
Biological Diversity,95 Brazil has enacted two important laws relating to 
GMP: Law No. 8.974, de 05 de Janeiro de 1995, D.O. de 06/0111995 
[hereinafter Law 8974], and Law No. 9.456, de 25 de abril de 1997, D.O. 
de 28/04/1997 [hereinafter Law 9456], and these Laws in connection 
with the Law 6938, de 31 de agosto de 1981, DO de 02/09/98 
[hereinafter Law 6938] establish the basic legal framework regulating 
this matter. Besides this basic legal framework, two others Laws should 
be mentioned here: the Law No. 7347, de 24 de julho de 1985, DO de 
25/07/1985 [hereinafter Law 7347], and Law No. 8078, de 11 de 
setembro de 1990, DO de 12/09/1990 [hereinafter Law 8078]. But what 
are the objectives of each of these laws? 
Law 6938 was enacted before the actual Brazilian Constitution, and 
through this Law the National Environmental Policy was established, 
electing CONAMA (Consellho National de Meio Ambiente - National 
Council of Environment) as the Council responsible for passing rules and 
defining standards to be followed in terms of environmental quality 
control. Basically, the objective of this policy is to allow sustainable 
development, making compatible social and economic development with 
94. FEDERATNE REPUBLIC OF BRAZIL CONSTITUTION - 1988, art. 225 § I (translated and 
revised by Istvan Vadja, Patricia de Queiroz Carvalho Zimbres and Yanira Tavares de Souza. 
Brasilia 1998) (II, N, Y, and Ym. 
95. Convention on Biological Diversity. Decreto No. 2519, de 16 de mar~o de 1998, DO de 
17/03/98. 
Brazil also signed the following multilateral agreements related to the environment: 
Antarctic -Environment Protocol, Antarctic Treaty, Climate Change, Desertification, Endangered 
Species, Environmental Modification, Hazardous Wastes, Law of the Sea Marine Dumping, Nuclear 
Test Ban, Ozone Layer Protection, Ship Pollution, Tropical Timber 83, Tropical Timber 94, 
Wetlands, and Whaling. Brazil also signed some bilateral agreements concerning environmental 
matters, including: one with Uruguay (Decreto Legislativo No. 74, de 04 de maio de 1995, DO de 
10/05/950) and another one with Mexico (Decreto No. 1575, de 31 de julho de 1995, DO de 
01108/1995) 
Finally, the relationship between an international agreement and the Brazilian Constitution 
or a Brazilian Law can be summarized in the following way: an international agreement in Brazil is 
considered inferior to the Constitution, and on the same level as federal law. So, it can be modified 
both by the Constitution and by subsequent federal law; it can modify prior federal law, but it can 
never modify Constitutional provisions. 
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the preservation of environment, ecological equilibrium, and natural 
resources. Based on this Law, CONAMA passed two administrative 
acts: (a) Resolu~ao No 001, de 23 de janeiro de 1986 [hereinafter 
RESOO 1], which provides in its Article 2 that the authorization of 
activities able to provoke changes in the environment will be subject to a 
prior environmental impact study, including an environmental impact 
report; moreover, it also establishes, in Article 6, II, how the 
environmental impact study should be prepared; and (b) Resolu~ao No 
237, de 19 de dezembro de 1997 [hereinafter RES237] complementing 
and modifying RES001 in order to clearly impose, as a mandatory 
procedure, the need for prior licensing in case of the introduction of 
genetically modified species in the environment (Article 2 § 1, annex 1; 
and Article 3), moreover, this license would be dependent on both an 
environmental impact study and an environmental impact report. 
Law 7347 regulates Civil Public Action (CPA). A CPA can be brought 
among other situations in case of damage caused to the environment or to 
consumers. According to this Law (Article 5, I and II), a CPA can be 
brought qy Federal Union, by States, by Municipalities, by an 
autonomous government agency, by Public Prosecution, by Public 
Companies, by Foundations, by Mixed Capital Companies, or by 
Association. An Association will be considered legitimate if it is in 
existence for at least one year, and if its activities include the protection 
of the environment or consumers (e.g., in Brazil, IDEC96 and 
Greenpeace97 are nowadays legitimate organizations for bringing a 
CPA). 
Law 8078 deals specifically with consumer protection, and among other 
rights, indicates as a basic right of consumers the right to be informed 
clearly and adequately about the specification, characteristics, 
composition, quality, price and risks of the products or services (Article 
6, III, and Articles 9 and 31), and the right to choose (Article 6, II). 
Law 8974 regulates Article 225, section I, II and V, of the Brazilian 
Constitution, and establishes rules to be observed when using genetic 
engineering in creating, manipUlating, transporting, commercializing, 
consuming, liberating, and disposing of genetically modified organisms 
96. IDEC (Instituto de Defesa do Consumidor), Conhe~a 0 IDEC (last visited Oct. 27, 1999) 
<www.uol.com.br/idec/oque.htm>. IDEC is the most important non-profit consumer association in 
Brazil. It initiated its activities in 1987, and its goal is the protection and defense of consumers. 
97. Greenpeace (Associa~ao Civil Greenpeace) (last visited Oct. 27, 1999) 
<www.greenpeace.org.br/vitoriaslbatalhas2.html>. Greenpeace is one of the most important 
environmental associations in the world, and it initiated its activities in Brazil in 1992. 
25
Oliveira Souza: Genetically Modified Plants
Published by GGU Law Digital Commons, 2000
154 ANNUAL SURVEY OF INT'L & COMPo LAW [Vol. 6:1 
in the environment. Basically, (a) this law regulates the environmental 
impact study and the environmental impact report; (b) this law allows the 
Executive Power to create a special commission (CTNBio) to be 
responsible, among other things, for establishing norms concerning the 
safety use of these techniques in Brazil, and determining if any specific 
use would be considered safe; (c) this law also establishes the 
competence of several federal agencies in dealing with this matter, 
stating, however, that all these agencies would observe the opinion of the 
CTNBio in the case.98 On November 30, 1998, through) an Executive 
Decree, Decreto Regulamentar No 1752, de 20 de dezembro de 1995, 
DO de 21112/95 (hereinafter DR 1752), the Executive Power officially 
created the CTNBio, connected to the Executive Secretary of the 
Ministry of Science and Technology. Among other things, DR 1752 
allows the President of CTNBio to decide when a prior environmental 
impact study or an environmental impact report would be necessary. The 
consequence of this innovation was to transform the constitutional 
requirement of prior environmental impact study (regulated by Article 
225, section 1, IV of the Brazilian Constitution, and discussed earlier) 
into a discretionary requirement, in a procedure that tis clearly 
unconstitutional. 
Law 9456 regulates· the intellectual property rights concerning a 
cultivated variety of a plant distinguished from other plants (also known 
as "cultivar"). The protection of intellectual property rights is done 
through a requirement in the SNPC (Servi~o Nacional de Prote~ao aos 
Cultivares), an agency subordinated to the Ministry of Agriculture and 
Food Supply. According to this Law, the SNPC will grant an applicant, 
subject to the fulfillment of other legal requirements, a certificate 
("Certificado de Prote~ao de Cultivar"), and this certificate would be not 
only proof that the applicant has intellectual property rights over the 
cultivar, but would also be proof that the applicant is the only one who 
98. Law No. 8974, de 05 de janeiro de 1995, D.O. de 28/04/97. Original text, in Portuguese, of 
the Caput and Law No. 8974, art. 7: "Regulamenta os incisos II e V do paragrafo 1 do art. 225 da 
Constitui~ao Federal, estabelece normas para uso das tecnicas de engenharia genetica e libera~ao no 
meio ambiente de organismos geneticamente modificados, autoriza 0 Poder Executivo Executivo 'a 
criar, no ambito da Presidencia da Republica, a Comissao Tecnica Nacional de Biosseguran~a, e da 
outras proviencias .... Cabera, dentre outras atribui~6es, aos 6rgaos de fiscaliza~ao do Ministerio da 
Saude, do Ministerio da Agricultura, do Abastecimento e da Reforma Agraria, e do Ministerio do 
Meio Ambiente e da Amazonia Legal, dentro do campo de suas competencias. Observado 0 parecer 
tecnico conclusivo da CTNBio e os mecanismos estabelecidos na regulamenta~ao desta Lei: .... " 
This Law (in article 14) also provides that those who causes damages to the environment and third 
parties will be responsible for repairing the damages or for paying compensation. 
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can produce, offer to sell, offer to commercially deal with, or authorize 
to produce/sell/commercially deal with the cultivar.99 
The complexity of the matter, the ambiguity of the legislation concerning 
GMP, the power granted to the CTNBio, the posture assumed by 
CTNBio in solving the questions related to GMP (indicating the adoption 
of the "American posture" instead of the "European posture," with a 
tendency to disregard the need for a prior environmental impact study), 
and finally, the failure of CTNBio to enact proper and specific 
legislation, created a perfect environment for legal disputes to arise. The 
first important dispute arose in 1997, and the second arose in 1998. 
The first dispute arose in December 1997, when the Brazilian Vegetable 
Oil Producers Association, based on authorization from the CTNBio, 
imported US genetically modified soy. This shipment arrived in the port 
of San Francisco do SuI - in Santa Catarina, a state located in the South 
of Brazil. Activists from Greenpeace prevented the unloading,loo and as a 
consequence ten activists were arrested by the Federal Police in Brazil 
the next day. 101 Following this action, Greenpeace brought a CPA 
(Process No. 1997.34.00.036170-4) against the Federal Union in the 
sixth Federal District Court, questioning the authorization granted by 
CTNBio and the importation of soy genetically engineered. Later, the 
Brazilian Vegetable Oil Producers Association and Monsanto do Brasil 
Ltda joined the action as defendants. 102 
The second dispute had its origin on June 15, 1998, when Monsanto 
initiated the process for the commercial exploitation in Brazil of the soy 
Roundup Ready (soy modified genetically for being tolerant to the 
pesticide glyphosate), applying for authorization from CTNBio. I03 On 
99. Law No. 9456, de 25 de abril de 1997, D.O. de 28/04/97, arts. 2, 4 and 9. 
100. Greenpeace Hazard Patrol Blocks U.S. Genetic Soya Landing in Brazil, (last visited Oct. 
24, 1999) <www.greenpeace.org/-geneng/>. 
101. Greenpeace Activists Arrested by the Brazilian Federal Police, (last visited Oct. 24, 1999) 
<www.greenpeace.org/-geneng/>. 
102. Ser;:iio Judiciaria do Distrito Federal - Resultado de Pesquisa, Process 1997.34.00.036170-
4 (6th Federal District Court) (last visited Oct. 24, 1999) <www.trf1.gov.br>. The action was 
brought on December 16, 1997 and there is no final decision in this case. However, an injunction 
was granted in July 1998 determining that CTNBio must instruct the importers about the obligation 
of labeling all foods in which the soy genetically engineered is used, and this decision was made 
based on the Law 8078. Greenpeace Protesta Contra Plantio de Soja Transgencia no Brasil, (last 
visited Oct. 24, 1999) <www.greenpeace.org.br>. 
103. Greenpeace Lanr;:a Campanha Publica pela Transformar;:iio do Rio Grande do Sui em 
Estado Livre de Transgenicos, (last visited Oct. 7, 1999) 
<www.greenpeace.org.biblioteca/imprensa/tche.html>. Why did Monsanto choose Brazil? Brazil as 
the main producer of soy in the world retain a strategic position: it would be more difficult for 
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December 30, 1998, CTNBio, through an internal act (Instrucs:ao 
Normativa No. 18, D.O. No. 250-E, de 30 de dezembro de 1998) 
[hereinafter IN 18], authorized the commercial exploitation by Monsanto 
do Brasil Ltda (the Brazilian subsidiary of U.S. Monsanto CO)I04 of the 
Soy Roundup Ready.IOS Following that, Monsanto applied and obtained, 
in accordance with Law 9456 (discussed earlier), the certificate 
(Certificado de Protecs:ao de Cultivar) from the SNPC (Servics:o Nacional 
de Protecs:ao ao Cultivar), protecting in this way its intellectual property 
rights on the following GMP: M-SOY 6363 RR, M-SOY 7777RR, M-
SOY 8080 RR, M-SOY 7979 RR and M-SOY 8888RR. 
Following this administrative decision, on November 5, 1998, IDEC 
brought a preparatory action (Process No. 1998.34.00.027681-8) against 
the Federal Union in the Eleventh Federal District Court in Sao Paulo, 
intending to obtain an injunction in order to bar any exploitation of the 
Soy Roundup Ready until a proper regulation governing the matter was 
enacted, and until a proper environmental impact study was prepared. 
The action was based on the following arguments: (a) CTNBio did not 
regulate'the matter, as determined by DR 1752; (b) CTNBio did not ask 
for a prior environmental impact study; and (c) in case of 
commercialization of GMP, even though labeling should have been 
mandatory, there was no regulation determining how it would be done.106 
A provisory injunction was granted and IDEC brought the main action (a 
CPA). Later, this case was removed to the Sixth Federal District Court, 
because of its similarity to the prior action brought by Greenpeace.107 
mAMA 108 joined the action as an author, Greenpeace joined the action 
as an assistant of the authors, and Monsanto do Brasil SI A and Monsoy 
Ltda joined the action as defendants. Finally, on August 10, 1999, the 
Sixth Federal District Court (federal judge Antonio Souza Prudente) 
decided the case in favor of IDEC, confirming the provisory injunction 
granted, and transforming this provisory injunction into a definitive 
order, holding in summary that commercial exploitation of the 
Monsanto's soy harvested in the United States and Argentina to be commercialized in Europe if 
Brazil were harvesting plants not genetically modified. 
104. THE WALL STREET JOURNAL INTERACTNE EDITION, Brazil's Monsanto Says Biotech Soy 
Intervention Overruled, Dow Jones Newswires, March 26, 1999 (last visited Oct. 6, 1999) 
<data.Free.de/gen.free.de!genet/1999IMar/msg00095.html>. 
105. InstrUl,ao Normativa No. 18, (last visited Sept. 9, 1999) 
<www.mct.gov.br/ctnbiotec!InstNormativas/InstnormatI8.htm>. 
106. IDEC, supra note 58. 
107. Se~ao Judiciana do Distrito Federal, Resultado de Pesquisa, Process 1998.34.00.02768-1 
(6th Federal District Court) (last visited Oct. 24, 1999) <www.trfl.gov.br>. 
108. mAMA (Instituto Brasileiro do Meio Ambiente) is a federal agency created by the law 
7735, de 22 de fevereiro de i989. Available in <: www.ibama.Gov.br/organiza.htm> and last visited 
on Oct. 27, 1999. 
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genetically modified soy "Roundup Ready" in Brazil by Monsanto must 
be subject to prior enactment of a proper and specific regulation 
concerning biosafety and labeling, and to the presentation of a prior 
. al . d 109 enVironment impact stu y .. 
Both judicial questions are not yet resolved, and in sum: (a) the action 
brought by Greenpeace (CPA) and the actions brought by IDEC 
(preparatory action and CPA) are together in the same court (Sixth 
Federal District Court); (b) in the action brought by Greenpeace, a 
preliminary injunction was granted and this injunction is not yet 
confinned; (c) in the action brought by IDEC, a preliminary injunction 
was granted and confinned the preparatory action decided in favor of 
IDEC; and finally (d) concerning the main actions (CPAs) there is no 
decision as yet. 
Three basic consequences arose from this judicial discussion: first, the 
SNPC obeyed the judicial decision in the case, suspending the effects of 
the registration by Monsanto of the following GMP: M-SOY 6363 RR, 
M-SOY 7777RR, M-SOY 8080 RR, M-SOY 7979 RR and M-SOY 
8888RR. 11O 
Second, this decision provoked a great debate in Brazil involving 
different areas of the government concerning not only GMP, but also 
related legislation, and the manner in which CTNBio conducted the 
process that led to importation of soy and the approval of the products by 
Monsanto;111 so, and for example: (a) EMBRAPA, the leader in soy 
research in Brazil and linked to the Ministry of Agriculture and Food 
Supply,112 was favorable to GMP;113 (b) on the other hand, one specialist 
from FIOCRUZ,114 Silvio Valle, said that "the ideal would be that Brazil 
109. Copia d<l Sentenl;a nos Autos da Arao Cautelar lnominada, No. 1998.34.00.027681-8 (last 
visited Oct. 25, 1999) <www.greenpeace.org.brlBibliotecalrelatorios/judicial.doc> visited on 
October 25, 1999. This decision is not final. In fact, Brazil presented an appeal on September 03,' 
1999, and this appeal has not yet been decided. 
110. Ministerio d<l Agricultura e do Abastecimento, SNPC - Servi"o Nacional de Prote,.ao de 
Cultivares - Noticias - 23 de Agosto de 1999 (last visited Sept. 9, 1999) 
<www.agricultura.gov.br/snpc/notlooO.htm>. 
111. 0 GLOBO ON, supra note 56. The original text in portuguese is: "0 mais novo 
adversario da pressa nas decisoes da CTNBio e 0 Ministro da Agricultura .... " 
112. EMBRAPA "is a public company, linked to the Ministry of Agriculture and Food Supply, 
with private company characteristics. It researches products that form part of the Brazilian table: 
from bread to meat, from milk to beans." Available at <www.embrapa.br/english/embrapa.htm> last 
visi ted on October 9, 1999. 
113. 0 GLOBO ON, supra note 43 
114. FIOCRUZ: "Oswald Cruz Foundation - FIOCRUZ, linked to the Brazilian Ministry of 
Health, develops actions in the area of science and technology in health .... " Available at 
<www.fiocruz.br/ingles/index.html> last visited on Oct 9, 1999. 
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create zones [based on ecological study] in order to allow the harvest of 
both soy [GMP and natural], being able to supply both markets;,,115 (c) 
following this idea, the most important agricultural states in Brazil 
affirmed that they will not allow the harvest of GMP in their 
territories;116 (d) the new president of SBPC (Brazilian Society for 
Development of Science), Glaci Zancan recognizes that the technology 
of GMP is something that will be adopted now or later, although "there 
are a lot doubts that need to be clarified through research done in Brazil 
because plants react in different ways according to the environment.,,117 
As an immediate consequence of these discussions, on August 31, 1999 
the new President of CTNBio indicated,118 that the policy of CTNBio has 
not changed, and it has maintained its position in the matter in three 
ways: (a) making available its website articles and scientific studies in 
favor of the use of GMP;"9 (b) publishing a book on the subject;120 and 
finally, organizing conferences about the subject. . 
Finally, issues concerning GMP were publicized in Brazil allowing the 
common people to be involved and informed about the matter. However, 
the involvement of the population is still low, and a recent survey 
supported by the newspaper "0 GLOBO" concerning GMF showed that: 
44% believe that GMF is not healthy, 38% had no opinion about the 
subject, and 18% considered GMF not harmful to health. 121 
115. 0 GLOBO ON, supra n 43. The original text in Portuguese is: "0 especialista em 
biosseguran«a Silvio Valle, da Fiocruz, diz que 0 ideal seria que 0 Brasil fizesse urn zoneamento 
ecol6gico para poder plantar soja transgenica e natural, atendendo assim a todos os mercados." 
116. Id. 
In. ld. The original text in Portuguese is: "Ainda ha muitas duvidas que precisam ser 
esclarecidas com pesquisas. Mas pesquisas realizadas no Brasil porque as plantas reagem de formas 
diferentes de acordo com 0 meio ambiente." 
liS. Noticias do MCT - Nomeada nova presidenta da CTNBio, (last visited Sept. 9, 1999) 
<www.mct.gov.brlsobrelnoticias/31_0S.htm>. 
119. C&T Brasil, Papers e Artigos, (last visited Sept. 9, 1999) <www.mct.gov.br/ 
ctnbiotec/artigos.htm>. Here five articles are mentioned: including one article published by the new 
CTNBio's President; two articles published in THE FINANCIAL TiMES; one scientific study by the 
Royal Society in England; and the position of the head of the Ministry of Science and Technology 
when talking to Federal Deputies. All this material shows that the discussion about this subject has 
not been done in a rational manner; that the development of GMP is morally acceptable and essential 
for fighting poverty; that there is no safe food, and that the most important thing is having basic 
standartls and requirements; that nowadays something around SO to 90% of all soy oil is made using 
GMP; that the most important thing in this debate is the consent by the consumer, who has the right 
to choose. 
120. C&T Brasil, Publica~Oes, Trangenicos, (last visited Sep. 19, 1999) 
<www.mct.gov.br/publiltransg.htm>. CTNBio indicates that although the book was sold out (more 
than 4,000 books were sold), it is still possible to have an online version of the book. The CTNBio 
indicates this matter now is "a bola da vez," an expression meaning basically that now everybody 
wants to talk about this, until another more important subject appears. 
121. 0 GLOBO ON (last visited Sept. 20,1999) <www.oglobo.com.br>. 
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So, what are the lessons to be drawn from this case? In sum, the 
Brazilian Case showed five things: (a) in times of globalization, 
sometimes a country is only a strategic detail for a multinational 
company; 122 (b) the existence of legislation is almost meaningless if it is 
unclear or not consolidated, allowing the introduction of GMP without 
any prior local risk assessment of the impact of this new culture on the 
environment; (c) any possible decision against GMP taken by the country 
(label, moratorium, ban, stringent legislation based on health or 
environmental concerns) will be considered a restriction on free 
commerce, with possible consequences in terms of the GATT 
Agreement; (d) any decision in favor of GMP may create additional 
difficulties for the producer to sell his produce; and (e) there are good 
arguments on both sides, making the matters related to GMP highly 
polemic and undefined. 
Then, should a developing or undeveloped country be a producer? Even 
though there is no standard answer to this question, the most appropriate 
answer seems to be: "No, at least not now!" The main support for this 
answer, considering all the uncertainties relating to the subject, is the 
precautionary principlel23 and the obligation of each state not to cause 
any environmental harm. 
Now it is time to analyze international regulation on the subject, 
including the effects of the GATT Agreement. 
C. GMP AND INTERNATIONAL REGULATION 
There is no specific international legislation concerning trade in GMP, 
despite all the discussions generated by this subject. The question is 
"why?" The reason is really simple; the most important economies are on 
completely different sides, and the efforts made by the . Biosafety 
Working Group (including representatives of over 100 States) in 
negotiating a draft Protocol to the Convention on Biological Diversity is 
a good example of that. Since 1996, this Group, as explained by Paul 
Hagen "has attempted to negotiate a draft Protocol to the Convention on 
Biological Diversity ... addressing risks relating to trade in genetically 
122. Greenpeace Lanfa Campanha Publica pela Transformafiio do Rio Grande do Sui em 
Estado Livre de Transgenicos, supra note 103. 
123. Hunter, supra note 38: "the precautionary principle switches the burden of scientific proof 
necessary for triggering policy responses from those who support prohibiting or reducing a 
potentially offending activity to those who wants to continue." 
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modified organisms ... the Cartagena Protocol on Biosafety,,,124 without 
final success. 
The last round of the negotiations of this Protocol occurred in Austria in 
September 1999. In this round the parties did not reach an agreement on 
how to stipulate norms concerning the transport, handling, and use of 
GMP in a commercial way, and again the main reason for the failure was 
the resistance of the so-called Miami Group (EVA, Canada, Australia, 
Argentina, Chile, and Vruguay).125 However, this round was not 
completely fruitless because: (a) a new meeting was scheduled for 
January 2000; and (b) the discussion concerning grains for food and feed 
is still open. Moreover, in a notice released by Greenpeace it was first 
made clear that "a significant development in Vienna was the firm 
resolve by the developing world to insist on their right to reject imports 
of GE commodities," and second that "genetic engineering is a new and 
untested technology which could have irreversible effects on the 
environment and requires a binding international agreement to give 
124. PAUL E. HAGEN ET AL., THE PROPOSED BIOSAFETY PROTOCOL TO THE CONVENTION ON . 
BIOLOGICAL DIVERSITY, at 143 (1999). Available in WESTLAW (SD66 ALI-ABA 139). The 
meeting happened in Cartagena in February 1999 (the Sixth Session). "The Biosafety Protocol 
negotiations represent the first attempt by governments of the world to agree upon a binding regime 
to address risks associated with biotechnology in a manner conductive to its productive development 
and use." 
Moreover, "the Biodiversity Convention's raison d'etre is habitat conservation and the 
equitable distribution of intellectual property rights flowing from biotechnology." Kevin C. 
Kennedy, The Illegality oj Unilateral Trade Measures to Resolve Trade-Environment Disputes, 22 
WM. & MARY ENVTL. L. POL'y REv. 375,389 (1998). 
125. WTO - US and Canada Continue to Obstruct Progress: Biosafety Talks Tiptoe Forward 
but Close Without Result, 20 September 1999, (last visited Oct. 10, 1999) 
<www.wto.orglwto!new!pressI40.htm>: Vienna -- The UN sponsored talks to set international rules 
on genetically engineered organisms (GMOs) closed in Vienna late Sunday night after taking some 
small steps forward. "The political commitment to the Protocol by all countries was reinforced, 
which is vital," said Louise Gale, the head of the Greenpeace delegation in Vienna. "Given the 
collapse of the negotiations in Cartagena, the decision to finally agree and sign the Biosafety Proto-
col in January 2000 is promising. But major issues such as how the Protocol will deal with grains 
meant for food and feed (i.e. commodities) are still open to question," said Gale. The major grain 
exporting countries, the US, Canada, Argentina, Australia, Chile and Uruguay have resisted includ-
ing commodities in the Protocol throughout the negotiations. A significant development in Vienna 
was the firm resolve by the developing world to insist on their right to reject imports of GE com-
modities. The Ethiopian delegate, Dr. Egziabher, crystallized their concern on Sunday when he said, 
"For us the right to say no is a matter of our survival." Grain exporters would prefer to have all 
GMO decisions treated as trade disputes by the World Trade Organization (WTO). "The great ma-
jority of the countries in Vienna rejected the demands made by a small minority of six countries," 
said Gale. "Genetic engineering is a new and untested technology which could have irreversible 
effects on the environment and requires a binding international agreement to give countries the right 
to protect their biodiversity. It is clear that the WTO is the wrong forum for GMOs." 
Moreover, according to Greenpeace (Austria Protocolo, Greenpeace Jaz Protesto em 
Abenura de Reuniao da ONU sobre Biosseguranra, (last visited Oct. 7, 1999) 
<www.greenpeace.org.brlbibliotecal imprensalaustriaprotocol.html»: "The Miami group consists 
of 6 major agricultural exporting countries." 
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countries the right to protect their biodiversity [and] it is clear that the 
WTO is the wrong forum for GMOs." 126 
In addition to the States having such different posltIons, Greenpeace 
added more elements to this discussion, demanding among other things 
that: "(a) The precautionary principle must be the overriding objective 
and basis for all decision-making under the Biosafety Protocol. Countries 
must be given international rights to ban or restrict the import and use of 
GMOs [genetically modified organisms, and here plants are included] 
and products thereof as precautionary measures. (b) Countries must be 
provided international rights to give their advance informed agreement 
for all GMOs and products thereof prior to all trans boundary movements. 
(c) The Biosafety Protocol must contain an international regime for 
liability and redress. (d) Countries must have the right under the 
Biosafety Protocol to require labeling and traceability of GMOs and 
products thereof for biosafety purposes. (e) The Biosafety Protocol must 
not be subordinate to other international agreements such as the World 
Trade Organization rules. (f) The Biosafety Protocol must prevent all 
releases of living modified organisms or products thereof into centres of 
genetic diversity and centres of origin. [and] (g) Trade with non-Parties 
to the Biosafety Protocol can only be permitted if it is on more 
environmentally stringent terms than those set out in the Protocol.,,127 
Despite all these difficulties, the final round of negotiations will happen 
in Montreal from January 20-28, 2000.128 However, the Protocol, if 
signed, may have its efficacy affected by the fact that, the United States 
is not a party to the Convention on Biological Diversity and therefore 
cannot be party to the Protocol until it ratifies the Convention.129 
126. Id. "The political commitment to the Protocol by all countries was reinforced, which is 
vital," said Louise Gale, the head of the Greenpeace delegation in Vienna. "Given the collapse of the 
negotiations in Cartagena, the decision to finally agree and sign the Biosafety Protocol in January 
2000 is promising. But major issues such as how the Protocol will deal with grains meant for food 
and feed (i.e. commodities) are still open to question," said Gale. The major grain exporting coun-
tries, the US, Canada, Argentina, Australia, Chile and Uruguay have resisted including commodities 
in the Protocol throughout the negotiations." 
127. X Negotiations for a Biosafety Protocol Proceed - Greenpeace Urges Government to 
Adopt Strong Standard, Vienna, Sept. 15, 1999 (last visited Oct. 9, 1999) 
<www.greenpeace.org/-geneng/>. 
128. X Final Day of the Informal Negotiationsfor Biosafety Protocol in Vienna, 19 Sept. 1999 
(last visited Oct. 9, 1999) <www.Greenpeace.org/-geneng/>. 
129. Hagen, supra note 124 at 163: "the United States, the world leader in Biotechnology is not 
a party to the [Convention on Biological Diversity] (CBD) and, therefore, cannot become a Party to 
the Protocol (unless it first ratifies the CBD), makes the dynamic all the more complex and volatile . 
. . [moreover] it is not clear whether such an agreement could survive a challenge at the WTO should 
it significantly impair the trading rights of the United States as a non-party." 
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In the absence of an international agreement specifically regulating the 
issue, what can the states do? Each State according to its own level of 
technology and respecting consumers' rights has been adopting its own 
solution. Basically, the countries have been adopting the following ways 
of protection: (a) ban or unilateral "de facto" moratorium; (b) internal 
legislation regulating approval and commercialization, imposing basic 
standards and/or mandatory labeling; and/or (c) external action asking 
for international regulation or an international moratorium on these 
products based on the need to protect not only the health of the 
popUlation but also of the environment. 
Only the first two ways of protection will be commented on here, 
because these two ways create a natural barrier impeding, or making 
more difficult, the free international commerce of these products, and as 
a consequence discussions may arise concerning the legality of such 
action in terms of the WTO/GATT Agreement. 
1. Ban or Unilateral "De Facto" Moratorium 
Ban, moratorium, and "de facto" moratorium are different concepts even 
though they have an equal effect of disrupting the free trade of goods. 
The consequences concerning the GATTIWTO will be commented on 
later, and here I will be assessing only how they differ from each other, 
with some examples. . 
A ban is a direct act prohibiting the commerce of some product in one 
country or among contracting parties to some international agreement 
(such as the EU). An example of a ban is the prohibition by EU (since 
1985) of commercialization of beef produced with synthetic hormones. 130 
Another example was when France, Luxembourg and Austria banned the 
cultivation of Bt corn. l3l 
A moratorium, on the other hand, is an act determining that something 
will be done later. It will be unilateral when determined by only one 
party, and it will be "de facto" when, even though there is no formal act 
declaring the moratorium, a country or institution delays or postpones 
some action. An example here is the "delay" by EU in approving some 
130. The United States Mission to the European Union, USTR Press Release on WTO 
Arbitration in Hormone Beef Case, (last visited Nov. 2, 1999) 
<www.useu.be/issues/beef0713.html>. 
131. Dunn, supra note 1 at 153-154: "France, Luxembourg and Austria, despite the approval by 
the European Commission, banned the cultivation of Bt com, based on an "EC Directive that allows 
member states to ban GMOs to protect the environment or for health reasons." 
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GMO products from EVA. 132 The point is that when a moratorium lasts 
for a long time, it may have the same effect as a ban. 
Another option for states is the adoption of a process of standardization 
and/or the institution of label requirements. 
2. Basic Standards and Labeling 
Basic standards and labeling are also different concepts, and both can be 
established by a local or international regulation. When a standard or·a 
labeling requirement is established by an international agreement it has 
the effect of making the market more predictable having, then, the effect 
of facilitating commerce among countries.133 The problem arises when a 
country unilaterally establishes standards or labels requirements, and 
when this happens there is a real probability of impairment of commerce. 
Basic standards, simply indicates the minimum requirement for a product 
being commercialized in a specific geographical area, such as health 
standards for food or national standards for electrical appliances. 134 In 
terms of international basic standards on food, the Codex Alimentarius 
reigns absolute, being also recognized by the WTOIGATI as an 
international standard; 135 in terms of local or regional standards, an 
example is the proposal of EV to stipulate the maximum level of 
genetically modified material to be accepted into foods by accident.136 
Labels, on the other hand, do not impose any internal requirement on the 
product. They only impose an external requirement in terms of 
information: some information about the product must be attached to the 
132. The United States Mission to the European Union. Glickman on Honnone Beef and 
Biotechnology, supra note 53: "For 1998 44% of our [USA] soybeans and 36% of our [USA] com 
are produced from genetically modified seeds. While only a few varieties of GMO products have 
been approved for sale and use in Europe, many more have been put on hold by a de facto European 
moratorium on new GMO products." 
133. RICHARD SCHAFFER ET AL., INTERNATIONAL BUSINESS LAw AND ITS ENVIRONMENT, 
West Educational Publishing Company, 383 (4th ed. 1998): "The GAIT 1994 Agreement on 
Technical Barriers to Trade . . . The Agreement recommends that countries develop and use 
internationally accepted standards where they exist. International standards will be presumed to be 
in compliance with GAIT." The same author, on pages 383 and 385, mentions the International 
Organization for Standardization as the most important source of international standards, and 
delineates ISO 9000 as the most common international standard. 
134. ld., at 323. 
135. Understanding the Codex Alimentarius - Codex and the Future (last visited Nov. 4, 1999) 
<www.fao.org/docrep/w9114e1W9114e09.htm>. For more detailed explanation about this Code, see 
generally supra note 70. 
136. The United States Mission to the European Union, EU Committee Accepts two Labeling 
Proposals for Biotech Food (last visited Nov. 2, 1999) <www.useu.br/eugmo1026.html>. 
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product. So, labeling has three basic functions: (a) it informs the 
consumer that some product is more or less dangerous to the consumer's 
health (making consumers more aware of the risks of the product),137 or 
to the environment (e.g., the voluntary European Eco-Label);138 (b) it 
protects consumers through a clear and honest exposure to the existing 
risks relating to the product; and (c) it allows consumers to make 
intentional choices, so if a similar product exists (in terms of 
characteristics, performance, taste, price and so on) it will enable the 
consumer to choose among them or opt for a substitute product. 
Labeling is another area in which the USA and EU diverge: while EU 
has a mandatory scheme of labeling for foods containing genetically 
modified ingredients, and is intending to widen the scope of such 
labeling,139 the USA does not require such labeling. 140 
But why do labels provoke so many fears among producers? There are 
two basic reasons: (a) first, if a label is mandatory, it would mean a loss 
of market, especially in a very educated consumer market (as in Europe, 
for example); and (b) second, labeling can be used as an instrument for 
making companies change procedures.141 As a matter of fact, labeling is 
137. Whittaker, supra note 32 at 1223: "labeling genetically engineered foods is required to 
alert consumers to the presence of such foods in their diet. " 
138. The European Union Eco-Label, (last visited Nov. 2, 1999) <europa.Eu.in/corrirnJdglll 
ecolabellindex.htm>: "The European Eco-Label Scheme ... is a major step forward in the co-
ordination of actions to promote environmentally friendly consumption. It enables European 
consumers to easily identify officially approved green products across the European Union, Norway, 
Liechtenstein and Iceland. It allows manufactures to show and communicate to their customers that 
their products respect the environment. 
139. The United States Mission to the European Union, supra note 53: "The European 
Commission is expected to adopt by the end of the year two measures concerning the labeling of 
bio-engineered food .. the second measure concerns the labeling of foods containing additives and 
flavorings produced from genetically modified material. While existing laws already include safety 
requirements for additives and flavorings, the EU said the proposed regulation would ensure that 
these foods are labeled in the same way as foods containing other genetically modified ingredients." 
140. [d. As Alan Larson, Assistant Secretary of State for Economic and Business Affairs, 
explains, the USA is "not convinced that it makes sense to engage in labeling when a product has no 
nutritional difference from other products or when it doesn' contain any type of allergens tat might 
cause people to have an allergic reaction .... We have no objection if a producer wishes to advertise 
a product and in labeling it or advertising it draws attention to characteristics that the producer thinks 
are important." 
141. Atsuko Okubo, Environmental Labeling Programs and the GATTIWTO Regime, 11 GEO. 
JNT'L ENVTL. L. REv. 599, 602 n.3 (1999). With respect to environmental labels, for example, 
Atsuko Okubo explains that: "because an environmental label is a market-oriented instrument, the 
underlying premise of a labeling program is that the strong environmental values of consumers can 
be used as a market force to leverage environmental improvement .... Labeling schemes will be 
successful if producers' response to the public pressure induced by the labeling schemes is 
significant enough to change their management procedures." 
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a powerful weapon for NGOs and other organized groups defending 
consumers and the environment. 
Just because of that, labeling has slowly assumed a very important role in 
the commerce of GMOs, including GMP, and the following examples 
demonstrate it: (a) the Codex Alimentarium Commission, as stated by 
Judith Beach "has issued draft recommendations for changes to the 
labeling of foods obtained through biotechnology"; 142 (b) in the 
European Union, and according to a EU release "foods and food 
ingredients produced from GMOs have to be labeled according to 
Regulation (EC) No 258/97 (Novel Foods Regulations) and Regulation 
(EC) Number 1139/98 (labeling of two particular GM soya and maize 
products). This means that they have to be labeled when they contain 
protein or DNA resulting from genetic modification.,,143 Terence Stuart 
and David Johanson, however, emphasize that" the regulation does not 
provide for the "may contain" labeling option for products for which it is 
not possible to determine whether they contain the relevant GMOs,,;I44 
and (c) the matter of eco-labeling today has also been discussed in the 
WTO/GA TT.145 
The question now is: do these possible measures (ban, moratorium, de 
facto moratorium, basic standards and labeling) fit into the WTO/GA TT 
scheme? 
142. Beach, supra note 50, at 188. 
143. The United States Mission to the European Union, supra note 53. 
144. Stuart, supra note 51, at 243. 
145. Eco-Labeling, (last visited Oct. 10, 1999) <www.wto.org/wto/environJeco.htm>. "Eco-
labeling programmes are important environmental policy instruments. Eco-labeling was discussed 
extensively in the GAIT, and that laid the basis in the CTE for a detailed examination of the issues 
involved. The key requirement from the WTO's point of view is that environmental measures that 
incorporate trade provisions or that affect trade significantly do not discriminate between home-
produced goods and imports, nor between imports from or exports to different trading partners. Non-
discrimination is the cornerstone of secure and predictable market access and undistorted competi-
tion: it guarantees consumer choice and it gives producers access to the full range of market oppor-
tunities. SUbject to that requirement being met, WTO rules place essentially no constraints on the 
policy choices available to a country to protect its own environment against damage either from 
domestic production or from the consumption of domestically produced or imported products. 
The CTE Report states that well-designed eco-labeling programmes can be effective in-
struments of environmental policy. It notes that in certain cases they have raised significant concerns 
about their possible trade effects. An important starting point for addressing some of those trade 
concerns is by ensuring adequate transparency in their preparation, adoption and application, in-
cluding affording opportunities for participation in their preparation by interested parties from other 
countries. Further discussion is needed on how the use in eco-labeling programmes of criteria based 
on non-product -related processes and production methods should be treated under the rules of the 
WTO Agreement on Technical Barriers to Trade." 
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D. EFFECT OF THE RULES OF WTO/GA IT 
The basic problem to be solved here is whether a ban, a moratorium, a 
"de facto" moratorium, and the imposition of basic standards or a label 
constitutes a violation of any WTO/GA IT provision. Two initial 
questions must be answered: (a) why is it important to know if there is a 
violation of any provision of WTO/GA IT? And (b) what are the basic 
provisions of WTO/GA TT? 
Currently 135 countries are members of WTO/GAIT. 146 The 
WTO/GA TT scheme provides an effective way for solving conflicts in 
case of violation of any WTO/GAIT provisions, and it is effective for 
four reasons: (1) Even though a member state can "block" or veto a panel 
decision, it does not happen very often, because, as explained by Richard 
Schaffer "they did not want to undermine a process for resolving 
disputes that they might want to use in the future. Furthermore, 
GATTIWTO panel decisions do carry the voice of world opinion and 
serve as an international conscience for determining which trade 
practices are acceptable and which are not,,;147 (2) If a party does not 
"block" or veto, the party must comply with the decision, and if the party 
does not comply, the other party may negotiate for compensation (Art 
22.2). If there is no agreement on compensation, the Dispute Settlement 
Body authorizes retaliation while pending full implementation (Art 22.2 
and 22.6), and this retaliation will be done considering products from the 
same sector, or products from different sectors, or finally any other 
international agreement in existence (Art. 22.3);148 (3) The WTO/GATT 
sets the basic rules concerning trade, and the violation of these rules may 
not only subject the violator to penalties under the WTO/GA TT scheme 
but also may subject the violator to other unilateral economic sanctions, 
such as the retaliatory measures provided by U.S. Section 301 (including 
the Basic Section 301, the Special 301, the Telecommunications 301, and 
the Super 301);149 (4) Finally, as explained by Atsuko Okubo, "in the 
event of a conflict between the WTO Agreement and any of the 
, 146. WHAT'S NEW, Estonia to Become 135th Member of WTO, Press Release (last visited Nov. 
4, 1999) <www.wto.org/wto/new/pressest.htm>. Moreover, 30 governments have applied to join the 
WTO, and their applications are still being considered. It is an impressive number considering that 
the United Nations nowadays has 185 members. 
147. SCHAFFER, ET AL., supra note 133, at 331. 
148. Settling Disputes (last visited Oct. 10, 1999) <www.wto.org/wto/aboutldisoute2.htm>. 
149. SCHAFFER ET AL., supra note 133, at 398-401. 
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multilateral trade agreements annexed to it, the WTO Agreement 
prevails.,,15o 
If it is important to comply with the rules of the WTO/GA IT scheme, it 
is necessary to identify the basic rules which can be summarized as 
follows: (a) According to Michael Trebilcock, GATTIWTO "commits 
member countries . . . to enter into 'reciprocal and mutually 
advantageous arrangements directed to the substantial reduction of tariffs 
and other barriers to trade and to the elimination of discretionary 
treatment in international commerce,,;151 (b) The WTO/GAIT scheme is 
supported by three basic concepts: 
(1) the principle of non-discrimination, including the most 
favored nation principle (MFN); 
(2) the principle of'national treatment; and 
(3) the elimination of quotas and any other non-tariff barriers. 
However, the GATTIWTO scheme realizes that in some specific and 
special situations these concepts may be disregarded. According to 
Michael Trebilcock, this can happen when these barriers or quantitative 
restrictions are imposed in order to protect "domestic supply 
management or agricultural marketing ... [or] if a country is facing 
serious balance of payment problems ... ,,,152 moreover, they will be also 
allowed when, and now according to Atsuko Okubo, they are "necessary 
to protect human, animal or plant life or health" (Article XX(b)), or [they 
are related] "to the conservation of exhaustible natural sources if such 
measures are made effective in conjunction with restrictions on domestic 
production or consumption (Article XX (g)).,,153 Richard Scheffer 
summarizes these exceptions in the following way: the restriction will be 
legitimate when present in one of the following legitimate objectives: 
"national security, preventing fraud or deception of consumers, 
protecting public health or safety, or protecting the environment.,,;154 (c) 
Even though some restrictions may be accepted, these restrictions may 
be considered as violations of the WTO/GA TT scheme if they violate the 
principle of least-restrictive trade, The meaning of this principle has been 
150. Okubo, supra note 141, at 603, 616. 
151. MICHAEL J TREBILCOCK AND ROBERT HOWSE, THE REGULATION OF INTERNATIONAL 
TRADE, Routledge: London, 25 (1995). 
152. [d., at.30. 
153. Atsuko Okubo, supra note 141, at 603,618. 
154. SCHAFFER ET AL., supra note 133, at 383. 
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explained by Richard Scheffer, who states that "a country in setting 
otherwise valid restriction on trade . . . shall make them no more 
restrictive than necessary to achieve the goals for which they were 
imposed.,,155 
The final comment here is that a very interesting phenomenon has 
happened concerning WTO/GA IT and the environment. WTO/GA TT 
has been recognizing (very slowly) the importance of environmental 
considerations in worldwide trade, and this started in 1994 with the 
inclusion in the WTO/GATT scheme of four agreements on 
environmental issues: the Agreement on the Application of Sanitary and 
Phytosanitary Measures (SPS Agreement), the Agreement on Technical 
Barriers to Trade (TBT Agreement), Agreement on Agriculture, and the 
Agreement on Subsidies and Countervailing Measures (SCM 
Agreement). 156 Following this trend, nowadays WTO/GA TT IS 
considering environmental issues as an important element in 
international trade, and WTO/GATT has recently made it clear when 
released a press statement stating that: "a new WTO Secretariat report 
argues that international economic integration and growth reinforce the 
need for sound environmental policies at the national and international 
level. International cooperation is particularly important in addressing 
transboundary and global environmental challenges beyond the control 
of any individual nation. This would be true even if nations did not trade 
with one another." 157 Moreover, WTO/GATT is also considering that its 
155. [d. at 383. 
156. Kennedy, supra 89. "The SPS Agreement applies to all sanitary and phytosanitary 
measures that may, directly or indirectly, affect international trade ... [and] expressly recognizes 
that Members have a legitimate right to protect human, animal, plant life and health, and to establish 
a level of protection for life and health that they deem appropriate .... The SPS Agreement requires 
Members to harmonize their SPS measures adopting international standards where such standard 
exist .... The most important [bodies developing such guidelines] are (l) the Codex Alimentarious 
Commission; (2) International Office of Epizootics ... and (3) the Secretariat of International Plant 
Protection Convention (IPPC) [p.397-4oo]. The TBT Agreement does not establish or prescribe 
standards, technical regulations, or conformity assessment procedures. Rather, it establishes general 
procedural requirements to be observed when adopting or using such measures so they do not create 
unnecessary obstacles to trade. . .. Members are encouraged to base their technical regulations on 
international standards where they exists ... [and] the leading international body involved in the 
drafting and promulgation of international technical standards is the International Standards 
Organization (lSO)[p. 408,412]. The SCM Agreement ... authorizes transitional assistance to firms 
for pollution abatement expenditures ... which makes environmental subsidies non-actionable, 
provided narrowly drawn criteria are met [po 417] .... The Agreement on Agriculture ... under the 
Agreement on Agriculture, developed-country Members agree to reduce their domestic agricultural 
subsidies twenty percent from 1986-88 base period levels by 2000 . . . expressly excluded are 
payments received under environmental programs [pAI8]." 
157. Press Release, Trade LiberaliztUion Reinforces the Needfor Environmental Cooperation, 8 
October 1999 (last visited Oct. 10, 1999) <www.wto.org/wto/new/pressI40.htm>. "The WTO 
Secretariat's Trade and Environment Report, to be released on 14 October 1999, addresses the eco-
nomic and political economy dimensions of the interface between trade and environment. The report 
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cooperative model, "based on legal rights and obligations, could 
potentially serve as a model for a new global architecture of 
environmental cooperation. ,,158 
It is time now to analyze the measures of ban, moratorium, "de facto" 
moratorium, establishment of basic standards, and labeling in the light of 
the WTO/GATT scheme. Do they fit into the WTO/GATT scheme? 
The answer is that all these measures represent an impairment of free 
trade; so they are considered "ab initio" a violation of the WTO/GA TT 
scheme. 
A country, or any other international entity, in adopting any of these 
measures should do it based on one or more allowed exceptions; 
moreover, the country needs to make sure first that there was no other 
less restrictive measure to be adopted, and second that there was a real 
reason for adopting the measure. The burden of proof will be on the 
country adopting the measure, and in the case of a measure adopted in 
order to protect human, animal or plant life or health this measure must 
be based on "sufficient scientific evidence.,,159 When adopting measures 
related to technical barriers to trade (e.g., basic standards and labels) the 
evaluation of the risks justifying the measure must be done based on 
"available scientific and technical information, related processing 
argues that there is no basis for the sweeping generalizations that are often heard in the public de-
bate, arguing that trade is either good for the environment, or bad for the environment. The real 
world linkages are a little bit of both, or a shade of gray. 'Win-win' outcomes can be assured through 
well designed policies in both the trade and environmental fields." 
This is a new position adopted by GATT. It is important to note that Kevin C. Kennedy, in 
1998 wrote that: "GATT-WTO system [and NAFfA] are viewed as at best indifferent to legitimate 
environmental concerns and at worst hostile to them. [Moreover, it is also important to mention] 
"that GATT has few friends among environmentalists, who vilify GATT and have made it their bete 
noire. [and one reason for that] "was the 1991 GATT panel report in the TunaJDolphin dispute 
between Mexico and the United States." [another "conflict" between GATT and environmentalist, 
happened when] "1992 GATT Report on Trade and Environment was published, which concluded 
that trade restrictions used for environmental purposes are likely to be counterproductive because 
they reduce world prosperity." [However, at the end, the Author concludes that] In short, instead of 
viewing free trade and environmental protection as mutually reinforcing, environmentalists' working 
premise is that the GATT-WTO system is an obstacle to environmental protection. Short of a no-
growth economic stance, this is a false premise. The GATT-WTO system and free trade are not 
environmental villains." See, Kevin C. Kennedy, The Illegality of Unilateral Trade Measures to 
Resolve Trade-Environment Disputes, 22 WM. & MARY ENVTL. L. POL'y REv. 375-377, 394-505 
(1998). 
158. [d. 
159. SCHAFFER ET At.., supra note 133, at 777. Article 2.2 of the Agreement on the Application 
of Sanitary and Phytosanitary Measures. 
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technology or intended end-uses of productS."l60 Scientific evidence as 
such has played an essential role in the adoption of restrictive measures. 
But how does it work in a practical sense? Two examples illustrate the 
application of these rules from WTO/GATT. The first example concerns 
labeling, and the issue is to consider if the label results "in discrimination 
against foreign producers and acts as' a non-tariff barrier to trade.,,161 If it 
happens, and if it is not protected by any other possible exception, the 
labeling will be against the WTO/GATT rules. One instance is the 
Tuna/Dolphin case, where the GATT upheld the labeling provisions in 
the Marine Mammal Protection Act (an American act enacted in 1972) 
on the grounds that "they applied equally to all nations fishing for tuna 
and did not restrict the sale of tuna productS.,,162 
The second example concerns a ban of a product, in this case beef 
produced by the USA. In 1985, the EU prohibited the importation of 
animals or their meat if they were treated with synthetic hormones for 
growth. On August 18, 1997, the WTO panel found that this ban was not 
based on "scientific evidence, a risk assessment, or relevant international 
standards, in contravention of the EU's obligations under SPS 
160. SCHAFFER ET AL., supra note 133, at 778. Article 2.2 of the Agreement on Technical 
Barriers to Trade. 
161. Okubo, supra note 141, at 603, 610. 
162. David Hunter et ai, supra note 32. The Tuna/Dolphin Case (a dispute between Mexico 
and the USA) is an excellent example of how an extraterritorial application of a domestic law can 
drive the creation of binding international law. This case can be summarized in the following way: 
In the eastern tropical Pacific Ocean (ETP) yellowfin tuna tend to swim beneath certain species of 
dolphin. As a consequence, dolphins were a bycatch during the fishing for yellowfin tuna. The U.S 
fleet dominated the tuna fishing in. the ETP and was responsible for more than 80% of the dolphins' 
death. It lead to the passage of the Marine Mammal Protection Act (MMPA) in 1972, imposing a 
reduction in the killing or incidental serious injury of marine mammals to insignificant levels 
approaching a zero mortality and serious injury rate. It was implemented through a General Permit 
and Observers placed on fishing vessels. This Act was Amended in 1981 (to define zero mortality); 
in 1984 (to impose trade restrictions banning importation of tuna into the US unless each nation 
exporting tune adopted a dolphin protection comparable to the protection adopted by the US); and in 
1988 (to impose trade restrictions on intermediary nations exporting tuna to the US). In 1990 
Congress passed the Dolphin Protection Consumer Information Act of 1990 (DPCIA), requiring that 
all tuna caught in the ETP and labeled "dolphin safe" must have been caught by a vessel too small to 
deploy its nets on dolphins, or have a certification from a qualified observer, or which did not 
harvest using a large-scale driftnet. Despite complaints that US actions violated GA TI and 
illegitimately restricted activities by sovereign nations, today dolphin mortality from the tuna fishery 
in the ETP has been reduced to 1 % of its previous level. Therefore, GA TI: (a) found that the 
MMPA import ban constitutes both quantitative restriction and illegitimately regulated the method 
by which the tuna was caught (p.1 029); (b) upheld labeling provisions because applied equally to all 
nations (p.1029); (c) found that a secondary embargo on intermediary markets also violated the 
GA TI (p.l 029). In response to this action by the US, the Inter-American Tropical Tuna Commission 
(IA TIC) adopted the La Jolla Agreement (p.1030), a non-binding multilateral program designed to 
reduce dolphin mortality in the ETP over a seven-year period to levels approaching zero, while 
maintaining the present maximum tuna yield. 
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Agreement.,,163 This decision was confirmed by the Appellate Body, and 
then adopted by the Dispute Settlement Body. Because EU failed to 
observe this decision in time it was determined that the EU had to make a 
payment of $116.8 million to the USA as compensation for damages. l64 
On July 29, 1999 USA started to collect it through a special tariff.165 
After seeing the situations in which a ban, a moratorium, a "de facto" 
moratorium, and the imposition of basic standards or a labeling will 
constitute violation of any WTOIGATT provisions; after seeing that the 
burden of proof is on the entity taking anyone of these restrictive 
measures; and finally, after seeing that the proof in WTOIGAIT is 
basically a scientific proof; it is now time to go to the conclusion and 
then pose the final question: is there a need for an international 
regulation? 
III. CONCLUSION 
As seen in the earlier sections, there is no specific international 
regulation concerning GMP; moreover: (a) there is great pressure from 
multinational companies to commercialize new GMP; (b) there is great 
pressure from countries where GMP has been harvested to make GMP 
accepted worldwide; (c) usually developing or less developed countries 
do not have proper legislation concerning GMP, and when they have 
such legislation, they have less bargaining or economic power to enforce 
it; (d) the possible measures to be adopted by countries not willing to 
accept GMP (e.g. ban, moratorium, "de facto" moratorium, basic 
standard, label) are "prima facie" against the provisions of the 
WTOIGA IT scheme; (e) there is no consensus regarding answers to the 
questions concerning the safety of GMP, in terms of environment or 
human health; and finally, (t) the provisions of the WTOIGAIT scheme 
imposing the burden of scientific proof on the country establishing the 
restrictive measure concerning GMP are absolutely in conflict with the 
precautionary principle. 
Considering the preceding facts, it is now time to attempt to answer the 
question: whether there is a need for an international regulation. 
163. The United States Mission to the European Union, supra note 132. 
164. The United States Mission to the European Union, USTR Fact Sheet on Dispute with EU 
over Beef Hormones (last visited Oct. 2, 1999) <www.useu.be/issueslhormone0713.html>. 
165. Final Product List in Beef Hormone Dispute (last visited Oct. 2, 1999) 
<www.ustr.gov/re1eases/ 1999/07/99-60.html>. 
43
Oliveira Souza: Genetically Modified Plants
Published by GGU Law Digital Commons, 2000
172 ANNUAL SURVEY OF INT'L & CaMP. LAW [Vol. 6:1 
The answer is in the affirmative. There is a clear need for an international 
regulation on GMP because: (a) the lack of clear legislation has been 
creating uncertainty in terms of safety and international trade; (b) the 
lack of clear legislation has been making it more difficult to perceive 
when a country is violating the principle of state responsibility, just 
because its obligations under international law are not clear (e.g., some 
actions or measures taken by an isolated state in order to protect its 
environment or the health of its population may violate some other 
international agreement); (c) the lack of clear legislation makes it more 
difficult for a country to observe its duty to assess environmental 
impacts, just because scientific findings are not absolutely conclusive in 
this matter, creating the possibility of discussion under WTO/GA IT 
(e.g., the Monarch Butterfly Case166); (d) the lack of clear legislation on 
the other hand makes it more difficult to identify when a country is 
violating its obligation not to cause environmental harm; (e) the lack of 
specific international legislation has been causing the impairment of 
commerce, and one of the consequences here may be the limitation on 
research and development of new biotech products; and finally, (f) the 
lack of specific international regulation has been creating a tension 
between international trade law and international environmental law. 
If there is a need for international regulation, the question now is: what 
kind of legislation? Should this legislation come as a chapter or appendix 
to any other international regulation already in existence (e.g., Biological 
Diversity, WTO/GAIT) or should it constitute a new and independent 
agreement? 
166. Prepared Statement of Ambassador David L. Aaron Under Secretary for International 
Trade, U.S. Department of Commerce, June IS, 1999 (last visited Oct. 2, 1999) 
<www.ogc.Doc.gov/ogcnegreg/testmonl106f/aaron0615.htm>. "Four varieties of U.S. developed 
"Bt", or pest-resistant com, have been in the EU approval process for over two years. The 
Commission has not approved any biotech products in a year and it recently announced that it was 
postponing the approval of Pioneer's Bt corn application because of recent findings on the effects of 
GMO corn on the U.S. monarch butterfly population." These findings resulted from a study by 
Cornell University, and' they are available at <www.greenpeace.org/ 
-geneng/reports/gmo/gmoOII.htm>. 
Immediately after the publication of these findings, a "consortium of biotechnology and 
pesticide companies quickly provided funds for several studies to qualify the risk posed by the 
genetically engineered, pest-resistant species known as Bt com [and the results, presented on 
November 2, 1999 in a scientific symposium in Chicago, USA, showed that] Genetically engineered 
com plans appear to pose only a modest threat to monarch butterflies .... " See, Gene-Spliced Com 
no Big Threat to Butterflies, Studies Say, S.F. CHRON. (East Bay Edition), Nov. 3, 1999, All. So, 
the questions here are: will new studies have a different conclusion? Can a scientific study be 
considered a conclusive proof? If there is uncertainty in terms of science, why not apply the 
precautionary principle? 
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This legislation should be in the form of a multilateral agreement, and it 
should constitute an appendix to WTO/GAIT. And the reasons are: (a) 
the consequences related to the .trade on GMP are global; (b) 
WTO/GA IT has 135 members, and among its members are 
preponderantly developed countries (this is not the case with the 
Convention on Biological Diversity, for example); and finally, (c) 
WTO/GAIT has an effective process for solving disputes among 
parties. 
Among other provlSlons, this new legislation should establish a 
moratorium on exploitation (allowing less developed or undeveloped 
countries to adjust their internal regulations), minimum standards 
(providing a minimum level of protection to be observed by all as a 
mandatory rule), and label requirements (guarantying the exercise of the 
right of choice by the consumers). Moreover, the most important 
recommended provision· is the adoption by this new legislation of the 
precautionary principle in terms of GMP (in case of uncertainty 
concerning the consequences of GMP to the environment or to the health 
of a population, the commercialization could be suspended). The 
adoption of this principle would not be in conflict with the principle of 
"scientific evidence" currently in existence within the WTO/GA IT 
scheme, and at the same time, it would be in accordance with general 
concepts and principles of international environmental law . 
As a matter of fact, the precautionary principle and the principle of 
"scientific evidence" would be compatible if the burden of proof shifted. 
Thus, the new legislation in terms of GMP simply should (a) first, allow 
any country to take a restrictive measure (label, ban or moratorium, or 
minimal standard) based on the precautionary principle, and (b) second, 
allow any country suffering the economic consequences of this measure 
to challenge the same, and this country would be responsible for proving 
scientifically that the GMP is absolutely safe to the environment and to 
human beings, so the change would mean only a shift in the burden of 
proof. 
These measures would also be in accordance with general concepts and 
principles of international environment law, especially the precautionary 
principle (discussed above), state responsibility (it would be clear which 
state would be responsible for taking the protective measures), the duty 
to assess environmental impacts, and the obligation not to cause 
environmental harm (in both these, the change in the burden of proof 
would allow for a better evaluation of the environmental impacts of 
GMP because of the need for strong proof against the presumption that 
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the GMP is unsafe, and it would allow the state to be in a better position 
to avoid environmental harm). 
Moreover, these measures would also be in accordance with other 
international documents, especially documents protecting human rights 
and nature. These documents, in sum, provide that: (1) human rights 
must be- respected,167 inclusive of international economic relations/68 
and among these human rights is the right to life (including proper 
nutrition and health)/69 and (2) any activity which may have an adverse 
impact on nature shall be controlled.,,17o The measures proposed would 
be in accordance with these documents simply because they would lead 
to the improvement of the quality and safety of food (thus improving the 
right to life), and they would also provide states with international 
redress for avoiding potential damage to the environment, thus allowing 
states to control activities that may have an impact on the environment. 
167. See also U.N. CHARTER (Chapter I - Purposes and Principles) arts. 1, 3. (Promoting and 
encouraging respect for human rights); UNNERSAL DECLARATION OF HUMAN RIGHTS art. 3. 
(Everyone has the right to life ... ). Available in LoUIS HENKIN ET AL., BASIC DOCUMENTS 
SUPPLEMENT TO INTERNATIONAL - CASES AND MATERIALS, St. Paul, MN: West Publishing 
Company, (3d ed. 1993). 
168. LoUIS HENKIN ET AL., BASIC DOCUMENTS SUPPLEMENT TO INTERNATIONAL - CASES AND 
MATERIALS, SI. Paul, MN: West Publishing Company, at 513 (3d ed. 1993). Ioternational 
Economic Cooperation: Chapter I - Fundamentals of Ioternational Economic Relations "Economic .. 
. and others relations among states shall be governed, inter alia, by the following principles: ... k) 
Respect for human rights and fundamental freedom." 
169. See CHARTER OF THE ORGANIZATION OF AMERICAN STATES, Art. 33. "The members 
states . . . agree to devote their utmost efforts to accomplishing the following basic goals: . . . j) 
proper nutrition, especially through the acceleration 'of natural efforts to increase the production and 
availability of food;" UNNERSAL DECLARATION OF HUMAN RIGHTS, art. 25(1). "Everyone has a 
right to a standard of living adequate for the health and well-being of himself and of his family, 
including food." 
170. LoUIS HENKIN ET AL., supra note 168 at 705. "World Charter for Nature ... n Functions . 
. . 11. Activities which might have impact on nature shaH be controlled .... " 
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